Part 4, Reference for Chapter 50: Immunobullous Diseases
Skip chapter table of contents and go to main content
Intraepidermal immunobullous diseases
- 1 Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009;7:434–40. Pubmed link , , , .
- 2 Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol 1974;38:382–7. Cross Ref link Pubmed link , , , .
- 3 Bullous pemphigoid and pemphigus vulgaris – incidence and mortality in the UK: population based cohort study. BMJ 2008;337:a180. Cross Ref link Pubmed link , , , , , .
- 4 Pemphigus. J Am Dermatol 1988;18:1219–38. Cross Ref link .
- 5 Pemphigus in North India. J Cutan Med Surg 2006;10:21–5. Cross Ref link Pubmed link , , .
- 6 Pemphigus in Pakistan, a study of 108 cases [corrected]. J Pakistan Med Assoc 1998;48:9–10. .
- 7 Epidemiology of pemphigus in south‐western Iran: a 10‐year retrospective study (1991–2000). Int J Dermatol 2006;45:103–5. Cross Ref link Pubmed link , , , .
- 8 Pemphigus vulgaris in a 3‐and‐one‐half‐year old boy. Arch Dermatol 1973;107:433–4. Cross Ref link Pubmed link , , , .
- 9 Juvenile pemphigus. J Am Dermatol 1983;8:799–807. Cross Ref link , .
- 10 Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol 1995;104:302–5. Cross Ref link Pubmed link , , , et al.
- 11 Pemphigus in Mali: a study of 30 cases. Br J Dermatol 1996;134:114–19. Cross Ref link Pubmed link , , , , .
- 12 Genetic factors in pemphigus. J Autoimmun 2005;24:319–28. Cross Ref link Pubmed link , , , et al.
- 13 Autoimmune diseases in patients with pemphigus and their first‐degree relatives. Int J Dermatol 2011;50:827–31. Cross Ref link Pubmed link , , , , .
- 14 Identification of a new disease cluster of pemphigus vulgaris with autoimmune thyroid disease, rheumatoid arthritis, and type I diabetes. Br J Dermatol 2014 Oct 1. , , , , .
- 15 The desmosome and pemphigus. Histochem Cell Biol 2008;130:21–54. Cross Ref link Pubmed link .
- 16 Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999;103:461–8. Cross Ref link Pubmed link , , , , , .
- 17 Correlation of antibodies in skin and serum with disease severity in pemphigus. Arch Dermatol 1979;115:428–32. Cross Ref link Pubmed link , .
- 18 Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982 May 20;306:1189–96. Cross Ref link Pubmed link , , , , .
- 19 In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti‐desmoglein 3 IgG autoantibodies in pemphigus vulgaris. J Invest Dermatol 2005;124:939–46. Cross Ref link Pubmed link , , , , , .
- 20 Significance of autoimmunity to non‐desmoglein targets in pemphigus. Autoimmunity 2006;39:549–56. Cross Ref link Pubmed link , .
- 21 The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol 1998;134:971–80. Pubmed link , , , et al.
- 22 Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 2004;9:29–33. Cross Ref link Pubmed link .
- 23 Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N‐terminal adhesive region of desmogleins. J Immunol 2001 Nov 1;167:5439–48. Cross Ref link Pubmed link , , , , , .
- 24 Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus. J Dermatol Sci 2007;48:1–14. Cross Ref link Pubmed link , , .
- 25 Apoptosis in pemphigus. Autoimmun Rev 2009;8:533–7. Cross Ref link Pubmed link , .
- 26 Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase‐8. J Invest Dermatol 2003;120:164–7. Cross Ref link Pubmed link , , , .
- 27 Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis. Exp Dermatol 2009;18:764–70. Cross Ref link Pubmed link , , , et al.
- 28 Familial pemphigus vulgaris. Dermatologica 1985;171:38–40. Cross Ref link Pubmed link , , .
- 29 Familial occurrence of pemphigus vulgaris. Arch Dermatol 1982;118:423–4. Cross Ref link Pubmed link , .
- 30 Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients. J Exp Med 1993 Feb 1;177:419–24. Cross Ref link Pubmed link , , , et al.
- 31 Circulating pemphigus IgG in families of patients with pemphigus: comparison of indirect immunofluorescence, direct immunofluorescence, and immunoblotting. J Am Dermatol 1997;36:44–52. Cross Ref link , , , et al.
- 32 Pemphigus vulgaris in Jewish patients is associated with HLA‐A region genes: mapping by microsatellite markers. Hum Immunol 2003;64:771–9. Cross Ref link Pubmed link , , , , , .
- 33 HLA‐A10 in pemphigus among Japanese. Arch Dermatol 1977;113:1518–19. Cross Ref link Pubmed link , , , .
- 34 Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris. Br J Dermatol 2006;154:67–71. Cross Ref link Pubmed link , , , et al.
- 35 The immunoglobulin heavy chain and disease association: application to pemphigus vulgaris. Hum Genet 1994;94:675–83. Cross Ref link Pubmed link , , , , .
- 36 Cytokine polymorphisms in patients with pemphigus. Arch Dermatol Res 2005;296:309–13. Cross Ref link Pubmed link , , , et al.
- 37 Endemic pemphigus foliaceus (fogo selvagem). I. Clinical features and immunopathology. J Am Dermatol 1989;20:657–69. Cross Ref link , , , et al.
- 38 Endemic pemphigus foliaceus (fogo selvagem): II. Current and historic epidemiologic studies. J Invest Dermatol 1989;92:4–12. Cross Ref link Pubmed link , , , et al.
- 39 Cooperative Group on Fogo Selvagem Research. Pathogenesis of endemic pemphigus foliaceus. Dermatol Clin 2011;29:413–18, viii. Cross Ref link Pubmed link , , ,
- 40 A case of pemphigus vulgaris improved by cigarette smoking. Arch Dermatol 2000;136:15–17. Cross Ref link Pubmed link , .
- 41 Pemphigus and associated environmental factors: a case‐control study. Clin Exp Dermatol 2007;32:256–60. Cross Ref link Pubmed link , , , et al.
- 42 Impact of smoking on pemphigus. Int J Dermatol 2008;47:567–70. Cross Ref link Pubmed link , , , et al.
- 43 Cholinergic control of epidermal cohesion. Exp Dermatol 2006;15:265–82. Cross Ref link Pubmed link .
- 44 Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 2001;40:562–9. Cross Ref link Pubmed link , , , et al.
- 45 Pesticide‐associated pemphigus vulgaris. Cutis 2008;82:51–4. Pubmed link , , , , , .
- 46 Contact pemphigus induced by dihydrodiphenyltrichlorethane. Eur J Dermatol 1998;8:442–3. Pubmed link , , .
- 47 Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol 2013;31:374–81. Cross Ref link Pubmed link , , , , , .
- 48 Pemphigus and dietary factors. In vitro acantholysis by allyl compounds of the genus Allium. Dermatology 1995;190:197–202. Cross Ref link Pubmed link , , , , .
- 49 Drug‐induced pemphigus. Clin Dermatol 2011;29:455–7. Cross Ref link Pubmed link , .
- 50 Drug‐induced pemphigus. Clin Dermatol 1986;4:118–32. Cross Ref link Pubmed link , .
- 51 Penicillamine‐induced bullous dermatoses. J Am Dermatol 1996;35(5 Pt 1):732–42. Cross Ref link , .
- 52 Penicillamine‐induced pemphigus. JAMA 1982 May 21;247:2705–7. Cross Ref link Pubmed link , , , .
- 53 Oesophageal involvement in pemphigus vulgaris. Lancet 1999 Nov 20;354(9192):1794. Cross Ref link Pubmed link , , , , .
- 54 Cervicovaginal involvement in pemphigus vulgaris: a clinical study of 77 cases. Br J Dermatol 2008;158:478–82. Cross Ref link Pubmed link , , , et al.
- 55 Nail involvement in pemphigus vulgaris. Br J Dermatol 2002;146:836–9. Cross Ref link Pubmed link , , .
- 56 Nail changes in pemphigus vulgaris. Int J Dermatol 2008;47:1141–4. Cross Ref link Pubmed link , , , et al.
- 57 Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus. J Am Acad Dermatol 2005;52:839–45. Cross Ref link Pubmed link , , , et al.
- 58 Cutaneous pemphigus vulgaris with absence of desmoglein 1 autoantibodies. An example of the extended desmoglein compensation theory. Australas J Dermatol 2014;55:292–5. Cross Ref link Pubmed link , .
- 59 Case of pemphigus foliaceus that shifted into pemphigus vulgaris after adrenal tumor resection. J Dermatol 2007;34:549–55. Cross Ref link Pubmed link , , , et al.
- 60 The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris. Br J Dermatol 2002;146:684–7. Cross Ref link Pubmed link , , , , , .
- 61 [Transition from pemphigus vulgaris to pemphigus foliaceus: a case report.] Ann Dermatol Venereol 2013;140:788–92. Cross Ref link Pubmed link , , , , , .
- 62 Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes. Obstet Gynecol Surv 2009;64:739–49. Cross Ref link Pubmed link , , , .
- 63 Pemphigus and pregnancy: a 23‐year experience. Indian J Dermatol Venereol Leprol 2011;77:534. Cross Ref link Pubmed link , , , et al.
- 64 Pemphigus vegetans: a clinical, histological, immunopathological and prognostic study. J Eur Acad Dermatol Venereol 2011;25:1160–7. Cross Ref link Pubmed link , , , et al.
- 65 Pemphigus vegetans. Neumann type and Hallopeau type. Int J Dermatol 1984;23:135–41. Cross Ref link Pubmed link , .
- 66 Detection of anti‐desmocollins I and II autoantibodies in two cases of Hallopeau type pemphigus vegetans by immunoblot analysis. J Dermatol Sci 1994;7:100–6. Cross Ref link Pubmed link , , , , , .
- 67 Two cases of pemphigus vegetans with IgG anti‐desmocollin 3 antibodies. JAMA Dermatol 2013;149:1209–13. Cross Ref link Pubmed link , , , et al.
- 68 Pemphigus herpetiformis: from first description until now. J Am Acad Dermatol 2014;70:780–7. Cross Ref link Pubmed link , , .
- 69 Pemphigus herpetiformis with IgA and IgG antibodies to desmoglein 1 and IgG antibodies to desmocollin 3. J Am Dermatol 2003;48:117–22. Cross Ref link , , , et al.
- 70 Pemphigus herpetiformis with IgG autoantibodies to desmoglein 1 and desmocollin 1. Br J Dermatol 2014 Sep 21. , , .
- 71 Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvagem, and pemphigus vulgaris. Cooperative Group on Fogo Selvagem Research. J Am Dermatol 1996;34:40–6. Cross Ref link , , , , , .
- 72 The men behind the eponym: Francis E. Senear, Barney Usher, and the Senear‐Usher syndrome. Am J Dermatopathol 2003;25:432–6. Cross Ref link Pubmed link , .
- 73 Autoantibodies in senear‐usher syndrome: cross‐reactivity or multiple autoimmunity? Autoimmune Dis 2012;2012:296214–17. Pubmed link , , .
- 74 Pathogenesis of pemphigus erythematosus. Arch Dermatol Res 1977 Apr 27;258:135–40. Cross Ref link Pubmed link , , , .
- 75 Paraneoplastic pemphigus. Australas J Dermatol 2013;54:241–50. Cross Ref link Pubmed link , .
- 76 Histologic features of paraneoplastic pemphigus. Arch Dermatol 1992;128:1091–5. Cross Ref link Pubmed link , .
- 77 Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. Dermatol Clin 2011;29:419–25, viii. Cross Ref link Pubmed link , .
- 78 IgA pemphigus. Clin Dermatol 2011;29:437–42. Cross Ref link Pubmed link , , , et al.
- 79 Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol 1997;109:127–31. Cross Ref link Pubmed link , , , et al.
- 80 IgG/IgA pemphigus with IgG and IgA antidesmoglein 3 antibodies and IgA antidesmoglein 1 antibodies detected by enzyme‐linked immunosorbent assay: a case report and review of the literature. Int J Dermatol 2010;49:298–302. Cross Ref link Pubmed link , , , et al.
- 81 IgA pemphigus reacting exclusively to desmoglein 3. Eur J Dermatol 2010;20:626–9. Pubmed link , , , , , .
- 82 IgA pemphigus in a child. J Am Dermatol 1991;25(2 Pt 2):383–6. Cross Ref link , , , et al.
- 83 A novel childhood pemphigus vegetans variant of intraepidermal neutrophilic IgA dermatosis. J Am Dermatol 1998;38:635–8. Cross Ref link , , , , , .
- 84 Intraepidermal neutrophilic IgA dermatosis in an HIV‐infected patient. J Am Dermatol 1994;31(3 Pt 1):502–4. Cross Ref link , .
- 85 Oral intraepidermal IgA pustulosis and Crohn's disease. Br J Dermatol 1992;126:383–6. Cross Ref link Pubmed link , , , et al.
- 86 Subcorneal pustular dermatosis‐type IgA pemphigus induced by thiol drugs. Eur J Dermatol 2001;11:41–4. Pubmed link , , , , .
- 87 Grading criteria for disease severity by pemphigus disease area index. J Dermatol 2014;41:969–73. Cross Ref link Pubmed link , , , et al.
- 88 Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. Eur J Dermatol 2007;17:4–11. Pubmed link , , , .
- 89 Severity score indexes for blistering diseases. Clin Dermatol 2012;30:108–13. Cross Ref link Pubmed link , , , , .
- 90 Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score. JAMA Dermatol 2014;150:266–72. Cross Ref link Pubmed link , , , et al.
- 91 Patterns of remission in pemphigus vulgaris. J Am Dermatol 2000;42:422–7. Cross Ref link , .
- 92 The course and prognosis of pemphigus. A review of 115 patients. Int J Dermatol 1988;27:580–4. Cross Ref link Pubmed link , , .
- 93 Pemphigus: analysis of 1209 cases. Int J Dermatol 2005;44:470–6. Cross Ref link Pubmed link , , , et al.
- 94 Outcome of pemphigus vulgaris. J Eur Acad Dermatol Venereol 2008;22:580–4. Cross Ref link Pubmed link , , , , , .
- 95 A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. Br J Dermatol 2000;143:343–8. Cross Ref link Pubmed link , , , , .
- 96 Prognostic factors in pemphigus vulgaris and pemphigus foliaceus. Br J Dermatol 2014;170:116–22. Cross Ref link Pubmed link , , , , , .
- 97 The value of immunofluorescence techniques in the diagnosis of bullous disorders: a review. Clin Exp Dermatol 1983;8:337–53. Cross Ref link Pubmed link , , .
- 98 Immunofluorescence tests. Clinical significance of sera and skin in bullous diseases. Int J Dermatol 1985;24:405–21. Cross Ref link Pubmed link , , .
- 99 A retrospective analysis of tissue‐fixed immunoreactants from skin biopsies maintained in Michel's medium. Dermatology 1994;189 Suppl. 1:131–2. Cross Ref link Pubmed link , , , , , .
- 100 Pemphigus vulgaris. Superior sensitivity of monkey esophagus in the determination of pemphigus antibody. Arch Dermatol 1981;117:561–2. Cross Ref link Pubmed link , , .
- 101 Comparative study of five serological assays for the diagnosis of paraneoplastic pemphigus. Pathology 2014 Dec 3;47:58–61. Cross Ref link , , , et al.
- 102 Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev 2010;10:84–9. Cross Ref link Pubmed link , .
- 103 Monitoring disease activity in pemphigus with enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol 2002;147:261–5. Cross Ref link Pubmed link , , , , , .
- 104 Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. Exp Dermatol 2010;19:458–63. Cross Ref link Pubmed link , , , et al.
- 105 Pemphigus‐like antibodies in patients with skin burns. Vox Sang 1969;16:73–5. Cross Ref link Pubmed link , , , , .
- 106 Sera from patients with toxic epidermal necrolysis contain autoantibodies to periplakin. Br J Dermatol 2006;155:337–43. Cross Ref link Pubmed link , , .
- 107 Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development? Arch Dermatol Res 2007;299(5–6):239–43. Cross Ref link Pubmed link , , , et al.
- 108 The distribution of pemphigus vulgaris‐IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first‐degree relatives. Br J Dermatol 2000;143:337–42. Cross Ref link Pubmed link , , , et al.
- 109 Current therapy of the pemphigus group. Clin Dermatol 2012;30:84–94. Cross Ref link Pubmed link , , .
- 110 Pemphigus: associations and management guidelines: facts and controversies. Clin Dermatol 2013;31:382–90. Cross Ref link Pubmed link , , , , , .
- 111 British Association of Dermatologists. Guidelines for the management of pemphigus vulgaris. Br J Dermatol 2003;149:926–37. Cross Ref link Pubmed link , , ,
- 112 Randomized controlled open‐label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol 2007;57:622–8. Cross Ref link Pubmed link , , , et al.
- 113 Pemphigus therapy with oral prednisolone regimens. A 5‐year study. Int J Dermatol 1990;29:363–7. Cross Ref link Pubmed link , , .
- 114 Pemphigus vulgaris with oral involvement: evaluation of two different systemic corticosteroid therapeutic protocols. J Eur Acad Dermatol Venereol 2002;16:353–6. Cross Ref link Pubmed link , , .
- 115 Intravenous dexamethasone‐cyclophosphamide pulse therapy in comparison with oral methylprednisolone‐azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. J Dtsch Dermatol Ges 2005;3:200–6. Cross Ref link Pubmed link , , , , , .
- 116 Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial. Arch Dermatol 2006;142:570–6. Cross Ref link Pubmed link , , , et al.
- 117 Azathioprine in the treatment of pemphigus vulgaris. A long‐term follow‐up. J Am Dermatol 1987;16(3 Pt 1):527–33. Cross Ref link , , , .
- 118 Randomized controlled open‐label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol 2007;57:622–8. Cross Ref link Pubmed link , , , et al.
- 119 A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol 2006;142:1447–54. Cross Ref link Pubmed link , , , et al.
- 120 Association of Dermatologists Therapy, Guidelines and Audit Subcommittee. Guidelines for prescribing azathioprine in dermatology. Br J Dermatol 2004;151:1123–32. Cross Ref link Pubmed link , , ,
- 121 Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo‐controlled trial. J Invest Dermatol 2010 Apr 22;130:2041–8. Cross Ref link Pubmed link , , , , , .
- 122 An evaluation of the usefulness of mycophenolate mofetil in pemphigus. Br J Dermatol 2003;149:138–45. Cross Ref link Pubmed link , , , et al.
- 123 Treatment of pemphigus with cyclophosphamide. Br J Dermatol 1975;93:573–6. Cross Ref link Pubmed link , , .
- 124 Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus. Br J Dermatol 2010;162:790–7. Cross Ref link Pubmed link , , , .
- 125 Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris. Am J Clin Dermatol 2007;8:85–92. Cross Ref link Pubmed link , , , et al.
- 126 Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment. J Am Dermatol 2001;45:679–90. Cross Ref link .
- 127 What's new in i.v. immunoglobulin therapy and pemphigus: high‐dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigus. J Dermatol 2010;37:239–45. Cross Ref link Pubmed link .
- 128 A randomized double‐blind trial of intravenous immunoglobulin for pemphigus. J Am Acad Dermatol 2009;60:595–603. Cross Ref link Pubmed link , , , et al.
- 129 Rituximab for pemphigus vulgaris. N Engl J Med 2007 Feb 1;356:521, author reply 521–2. Cross Ref link Pubmed link , , .
- 130 Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med 2006 Oct 26;355:1772–9. Cross Ref link Pubmed link , , , .
- 131 Clinical and immunological outcomes of high‐ and low‐dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer‐blinded study. Br J Dermatol 2014;170:1341–9. Cross Ref link Pubmed link , , , et al.
- 132 Rituximab exerts a dual effect in pemphigus vulgaris. J Invest Dermatol 2008;128:2850–8. Cross Ref link Pubmed link , , , , , .
- 133 Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients. Br J Dermatol 2011 Oct 17;166:154–60. Cross Ref link Pubmed link , , , et al.
- 134 Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases. J Dtsch Dermatol Ges 2012;10:727–32. Pubmed link , , , et al.
- 135 A drug safety evaluation of rituximab and risk of hepatitis B. Exp Opin Drug Saf 2014;13:977–87. Cross Ref link , .
- 136 Plasma exchange in the treatment of pemphigus vulgaris. Br J Dermatol 1978;98:243. Cross Ref link Pubmed link , , .
- 137 Controlled study of plasma exchange in pemphigus. Arch Dermatol 1988;124:1659–63. Cross Ref link Pubmed link , , , et al.
- 138 Immunoadsorption in dermatology. Arch Dermatol Res 2010;302:241–53. Cross Ref link Pubmed link , .
- 139 Immunoadsorption in pemphigus. Autoimmunity 2006;39:609–16. Cross Ref link Pubmed link , .
- 140 Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication. J Eur Acad Dermatol Venereol 2014;28:771–80. Cross Ref link Pubmed link , , , et al.
- 141 Cyclosporine therapy should be considered for maintenance of remission in patients with pemphigus. Arch Dermatol 2001;137:505–6. Pubmed link , .
- 142 Long‐term remission in selected patients with pemphigus vulgaris treated with cyclosporine. J Am Dermatol 1997;36(2 Pt 1):264–6. Cross Ref link , , .
- 143 Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol 2000;136:868–72. Pubmed link , , .
- 144 Use of topical cyclosporin in oral pemphigus. J Am Dermatol 1998;38(5 Pt 2):860–1. Cross Ref link , .
- 145 Treatment of pemphigus with gold. Arch Dermatol 1998;134:1104–7. Cross Ref link Pubmed link , .
- 146 Gold: an old drug still working in refractory pemphigus. J Eur Acad Dermatol Venereol 2007;21:902–7. Cross Ref link Pubmed link , , , , , .
- 147 Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data. Am J Clin Dermatol 2009;10:383–96. Cross Ref link Pubmed link , .
- 148 Multicenter randomized, double‐blind, placebo‐controlled, clinical trial of dapsone as a glucocorticoid‐sparing agent in maintenance‐phase pemphigus vulgaris. Arch Dermatol 2008;144:25–32. Cross Ref link Pubmed link , , , et al.
- 149 Successful treatment of pemphigus vegetans by addition of etretinate to systemic steroids. Clin Exp Dermatol 1998;23:178–80. Cross Ref link Pubmed link , , .
- 150 Methotrexate as an adjuvant treatment for pemphigus vulgaris. Arch Dermatol 1999;135:1275–6. Cross Ref link Pubmed link , .
- 151 Pemphigus vulgaris treated with photopheresis. J Am Dermatol 1992;26(5 Pt 1):779–80. Cross Ref link , , .
- 152 Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis. J Am Dermatol 1993;28:122–4. Cross Ref link , , , .
- 153 Infliximab in the management of severe pemphigus vulgaris. Br J Dermatol 2005;153:222–3. Cross Ref link Pubmed link , , , , , .
- 154 Pemphigus vulgaris treated with adalimumab: case study. Dermatol Ther 2012;25:95–7. Cross Ref link Pubmed link , , , .
- 155 Autoimmune bullous skin diseases occurring under anti‐tumor necrosis factor therapy: two case reports. Dermatology 2010;221:201–5. Cross Ref link Pubmed link , , , et al.
- 156 Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases. J Am Dermatol 1993;28:998–1000. Cross Ref link , , .
- 157 Two decades of using the combination of tetracycline derivatives and niacinamide as steroid‐sparing agents in the management of pemphigus: defining a niche for these low toxicity agents. J Am Acad Dermatol 2014;71:475–9. Cross Ref link Pubmed link , .
Subepidermal immunobullous diseases
Bullous pemphigoid
- 158 Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002;195:747–57. Cross Ref link Pubmed link , , , , .
- 159 Pemphigoid diseases. Lancet 2013;381:320–32. Cross Ref link Pubmed link , .
- 160 Identification and partial characterization of a novel 105‐kDalton lower lamina lucida autoantigen associated with a novel immune‐mediated subepidermal blistering disease. J Invest Dermatol 1993;101:262–7. Cross Ref link Pubmed link , , , et al.
- 161 The alpha 5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency. J Biol Chem 2000;275:16002–6. Cross Ref link Pubmed link , , , .
- 162 Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Dermatol Clin 2011;29:453–58, ix. Cross Ref link Pubmed link .
- 163 Identification of a 160‐kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen. J Invest Dermatol 1990;94:817–21. Cross Ref link Pubmed link , , .
- 164 Linear IgA disease: the IgA and IgG response to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180‐kDa protein. Br J Dermatol 2003;149:1055–8. Cross Ref link Pubmed link , .
- 165 Pemphigus. Medicine 1953;32:1–123. Cross Ref link Pubmed link .
- 166 Basement zone antibodies in bullous pemphigoid. JAMA 1967;200:751–6. Cross Ref link Pubmed link , , , , , .
- 167 Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 1986;136:1231–5. Pubmed link , , , , .
- 168 Isolation of a human epidermal cDNA corresponding to the 180‐kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest 1990;86:1088–94. Cross Ref link Pubmed link , , , et al.
- 169 Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 1981;24:897–903. Cross Ref link Pubmed link , , , , .
- 170 A passive transfer model of the organ‐specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993;92:2480–8. Cross Ref link Pubmed link , , , et al.
- 171 Humanization of autoantigen. Nat Med 2007;13:378–83. Cross Ref link Pubmed link , , , et al.
- 172 Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania. Int J Dermatol 2010;49:768–74. Cross Ref link Pubmed link , , , et al.
- 173 Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol 2004;43:876–81. Cross Ref link Pubmed link , , , , .
- 174 Epidemiological and clinical analysis of pemphigoid patients in northeastern Poland in 2000–2005. Med Sci Monit 2007;13:CR360–4. Pubmed link , , , , .
- 175 Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2‐year review. Br J Dermatol 2002;147:476–80. Cross Ref link Pubmed link , .
- 176 Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009;7:434–40. Pubmed link , , , .
- 177 Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North‐east Scotland. Br J Dermatol 2005;153:424–7. Cross Ref link Pubmed link , , , et al.
- 178 Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2‐year prospective study. Br J Dermatol 2009;161:861–8. Cross Ref link Pubmed link , , , et al.
- 179 Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 2012;132:1998–2004. Cross Ref link Pubmed link , , , et al.
- 180 [Epidemiology of bullous pemphigoid in Guadeloupe (French West Indies).] Ann Dermatol Venereol 2009;136:907–9. Cross Ref link Pubmed link , , , , , .
- 181 Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009. J Am Acad Dermatol 2014;71:92–9. Cross Ref link Pubmed link , , , et al.
- 182 Bullous pemphigoid and pemphigus vulgaris – incidence and mortality in the UK: population based cohort study. BMJ 2008;337:a180. Cross Ref link Pubmed link , , , , , .
- 183 Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995;131:957–8. Cross Ref link Pubmed link , , , , , .
- 184 Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 1995;131:48–52. Cross Ref link Pubmed link , , , et al.
- 185 Risk factors for bullous pemphigoid in the elderly: a prospective case‐control study. J Invest Dermatol 2011;131:637–43. Cross Ref link Pubmed link , , , et al.
- 186 The relationship between neurological disease and bullous pemphigoid: a population‐based case‐control study. J Invest Dermatol 2010;131:631–6. Cross Ref link Pubmed link , , .
- 187 The association of bullous pemphigoid with cerebrovascular disease and dementia: a case‐control study. Arch Dermatol 2010;146:1251–4. Cross Ref link Pubmed link , , , , , .
- 188 Drugs associated with bullous pemphigoid. A case‐control study. Arch Dermatol 1996;132:272–6. Cross Ref link Pubmed link , , , et al.
- 189 The associations between bullous pemphigoid and drug use: a UK case‐control study. JAMA Dermatol 2013;149:58–62. Cross Ref link Pubmed link , , , .
- 190 Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol 2011;165:368–74. Cross Ref link Pubmed link , , , , .
- 191 Prevalence and clinical features of Thai patients with bullous pemphigoid. Asian Pac J Allergy Immunol 2011;29:66–72. Pubmed link , , , , .
- 192 Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States. J Am Acad Dermatol 2008;59:582–8. Cross Ref link Pubmed link , , , et al.
- 193 Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol 2002;138:903–8. Cross Ref link Pubmed link , , , et al.
- 194 Mortality of bullous pemphigoid in China. JAMA Dermatol 2013;149:106–8. Cross Ref link Pubmed link , , .
- 195 Increased risk of bullous pemphigoid in male and very old patients: A population‐based study on incidence. J Am Acad Dermatol 1999;41:266–8. Cross Ref link Pubmed link , , , , .
- 196 Bullous pemphigoid in infancy: case report and literature review. Pediatr Dermatol 1998;15:108–11. Cross Ref link Pubmed link , , , .
- 197 Childhood bullous pemphigoid. Clinical and immunologic features, treatment, and prognosis. Arch Dermatol 1991;127:378–86. Cross Ref link Pubmed link , , , .
- 198 Bullous pemphigoid in infancy: Clinical and epidemiologic characteristics. J Am Acad Dermatol 2008;58:41–8. Cross Ref link Pubmed link , , , et al.
- 199 Neurological disorders in patients with bullous pemphigoid. Dermatology 2007;215:187–91. Cross Ref link Pubmed link , , , et al.
- 200 Comorbidity profiles among patients with bullous pemphigoid: a nationwide population‐based study. Br J Dermatol 2011;165:593–9. Cross Ref link Pubmed link , , , et al.
- 201 Bullous pemphigoid and internal diseases – A case‐control study. Eur J Dermatol 2010;20:96–101. Pubmed link , , , , , .
- 202 Distribution of collagen XVII in the human brain. Brain Res 2007;1158:50–6. Cross Ref link Pubmed link , , , , .
- 203 The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles. J Cell Biol 2001;154:691–7. Cross Ref link Pubmed link , , , .
- 204 Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 1995;81:233–43. Cross Ref link Pubmed link , , , et al.
- 205 Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil. J Dermatol 2012;39:884–5. Cross Ref link Pubmed link , , .
- 206 Association of pemphigus and bullous pemphigoid with thyroid autoimmunity in Caucasian patients. J Am Acad Dermatol 2013;68:687–9. Cross Ref link Pubmed link , , , , , .
- 207 Bullous pemphigoid and autoimmunity. J Am Acad Dermatol 1993;29:181–4. Cross Ref link Pubmed link , , , .
- 208 Pemphigoid and cancer. Arch Dermatol 1990;126:66–8. Cross Ref link Pubmed link , , , .
- 209 The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci 1995;9:136–41. Cross Ref link Pubmed link , , , et al.
- 210 Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999‐2011. Arch Dermatol Res 2014;306:75–80. Cross Ref link Pubmed link , , , , .
- 211 Malignancies in pemphigus and pemphigoid diseases. J Invest Dermatol 2015;135:1445–7. Cross Ref link Pubmed link , , , , , .
- 212 Emerging treatments for pemphigoid diseases. Trends Mol Med 2013;19:501–12. Cross Ref link Pubmed link , , , , .
- 213 Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol 2008;128:415–26. Cross Ref link Pubmed link , , , et al.
- 214 Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 1997;109:573–9. Cross Ref link Pubmed link , , , et al.
- 215 Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non‐collagenous site on the BP180 ectodomain. J Immunol 1993;151:5742–50. Pubmed link , , , , , .
- 216 Evaluation of a BP180‐NC16a enzyme‐linked immunosorbent assay in the initial diagnosis of bullous pemphigoid. Br J Dermatol 2004;151:126–31. Cross Ref link Pubmed link , , , , , .
- 217 Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid. J Dermatol Sci 2005;37:145–9. Cross Ref link Pubmed link , , , , , .
- 218 Development of a novel ELISA system for detection of anti‐BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients. Br J Dermatol 2004;151:1004–10. Cross Ref link Pubmed link , , , et al.
- 219 Enzyme‐linked immunosorbent assay using multimers of the 16th non‐collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 2007;16:770–7. Cross Ref link Pubmed link , , , et al.
- 220 BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002;30:224–32. Cross Ref link Pubmed link , , , et al.
- 221 Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000;136:174–8. Cross Ref link Pubmed link , , , .
- 222 Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Int J Dermatol 2008;47:225–8. Cross Ref link Pubmed link , , , , , , .
- 223 Clinical significance of enzyme‐linked immunosorbent assay for the detection of circulating anti‐BP180 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 2001;26:14–18. Cross Ref link Pubmed link , , , et al.
- 224 IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol 2000;42:577–83. Pubmed link , , , , , .
- 225 IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180. J Invest Dermatol 1999;112:141–7. Cross Ref link Pubmed link , , , et al.
- 226 Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2‐ and COOH‐terminal regions of the BP180 ectodomain. J Invest Dermatol 2002;119:1065–73. Cross Ref link Pubmed link , , , et al.
- 227 Demonstration of epitope‐spreading phenomena in bullous pemphigoid: results of a prospective multicenter study. J Invest Dermatol 2011;131:2271–80. Cross Ref link Pubmed link , , , et al.
- 228 Characterization of the anti‐BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients. J Invest Dermatol 2004;122:103–10. Cross Ref link Pubmed link , , , et al.
- 229 Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. Arch Dermatol 2008;144:41–8. Cross Ref link Pubmed link , , , et al.
- 230 A novel ELISA reveals high frequencies of BP180‐specific IgE production in bullous pemphigoid. J Immunol Methods 2009;346:18–25. Cross Ref link Pubmed link , , , , .
- 231 Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun 2000;15:293–300. Cross Ref link Pubmed link , , , et al.
- 232 IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis. Br J Dermatol 2000;143:349–55. Cross Ref link Pubmed link , , , , , .
- 233 Development of an ELISA for the detection of autoantibodies to BP230. Clin Immunol 2004;111:146–52. Cross Ref link Pubmed link , , , , .
- 234 BP230‐ and BP180‐specific auto‐antibodies in bullous pemphigoid. J Invest Dermatol 2004;122:1413–22. Cross Ref link Pubmed link , , , et al.
- 235 Enzyme‐linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci 2006;41:21–30. Cross Ref link Pubmed link , , , et al.
- 236 Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid. Ann N Y Acad Sci 2009;1173:15–20. Cross Ref link Pubmed link , , , et al.
- 237 Epitope mapping of BP230 leading to a novel enzyme‐linked immunosorbent assay for autoantibodies in bullous pemphigoid. Br J Dermatol 2012;166:964–70. Cross Ref link Pubmed link , , , et al.
- 238 Usefulness of BP230 and BP180‐NC16a enzyme‐linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Arch Dermatol 2011;147:286–91. Cross Ref link Pubmed link , , , et al.
- 239 Enzyme‐linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid. Arch Dermatol 2011;147:293–8. Cross Ref link Pubmed link , , , et al.
- 240 IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH‐terminus of BP230. J Invest Dermatol 2000;114:998–1004. Cross Ref link Pubmed link , , , et al.
- 241 IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid. J Immunol 1996;157:3642–7. Pubmed link , , , et al.
- 242 T cell control in autoimmune bullous skin disorders. J Clin Invest 2006;116:1159–66. Cross Ref link Pubmed link , , .
- 243 Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. J Immunol 2006;176:2015–23. Cross Ref link Pubmed link , , , , , .
- 244 Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998;102:2082–9. Cross Ref link Pubmed link , , , et al.
- 245 Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J Invest Dermatol 2000;115:955–61. Cross Ref link Pubmed link , , , et al.
- 246 Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid. Exp Dermatol 2007;16:13–21. Cross Ref link Pubmed link , , , .
- 247 Reduced numbers of circulating gammadelta T cells in patients with bullous pemphigoid. Exp Dermatol 2009;18:991–3. Cross Ref link Pubmed link , , , , , .
- 248 Follicular helper T cells (Tfh) and IL‐21 involvement in the pathogenesis of bullous pemphigoid. PLOS One 2013;8:e68145. Cross Ref link Pubmed link , , , et al.
- 249 Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity 2011;45:55–70. Cross Ref link Pubmed link , , .
- 250 Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis? G Ital Dermatol Venereol 2009;144:339–49. Pubmed link , .
- 251 Skin‐homing interleukin‐4 and ‐13‐producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin‐10‐producing cells. J Invest Dermatol 2001;117:1097–102. Cross Ref link Pubmed link , , .
- 252 Lesional Th17 cells and regulatory T cells in bullous pemphigoid. Exp Dermatol 2011;20:1022–4. Cross Ref link Pubmed link , , , et al.
- 253 Autoantibodies to BP180 associated with bullous pemphigoid release interleukin‐6 and interleukin‐8 from cultured human keratinocytes. J Invest Dermatol 2000;115:842–8. Cross Ref link Pubmed link , , , et al.
- 254 IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180‐kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment. J Invest Dermatol 2009;129:919–26. Cross Ref link Pubmed link , , , et al.
- 255 Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway. Am J Pathol 2013;182:828–40. Cross Ref link Pubmed link , , , et al.
- 256 FcR‐independent effects of IgE and IgG autoantibodies in bullous pemphigoid. J Immunol 2011;187:553–60. Cross Ref link Pubmed link , , , .
- 257 Autoantibodies to bullous pemphigoid antigen 180 induce dermal‐epidermal separation in cryosections of human skin. J Invest Dermatol 2002;118:664–71. Cross Ref link Pubmed link , , , , , .
- 258 Granulocyte‐derived elastase and gelatinase B are required for dermal‐epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 2004;204:519–27. Cross Ref link Pubmed link , , , et al.
- 259 FcgammaRIIA and FcgammaRIIIB are required for autoantibody‐induced tissue damage in experimental human models of bullous pemphigoid. J Invest Dermatol 130:2841–4. Cross Ref link Pubmed link , , , , , .
- 260 92‐kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180‐kD bullous pemphigoid autoantigen. J Clin Invest 1994;93:2022–30. Cross Ref link Pubmed link , , , .
- 261 Increased expression of matrix metalloproteinase‐2, matrix metalloproteinase‐9 and matrix metalloproteinase‐13 in lesional skin of bullous pemphigoid. Int Arch Allergy Immunol 2006;139:104–13. Cross Ref link Pubmed link , , .
- 262 Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid. J Invest Dermatol 2001;117:1091–6. Cross Ref link Pubmed link , , , , .
- 263 The role of complement in experimental bullous pemphigoid. J Clin Invest 1995;95:1539–44. Cross Ref link Pubmed link , , , et al.
- 264 Role of different pathways of the complement cascade in experimental bullous pemphigoid. J Clin Invest 2006;116:2892–900. Cross Ref link Pubmed link , , , et al.
- 265 Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage‐mediated neutrophil infiltration depends on mast cell activation. J Immunol 2002;169:3987–992. Cross Ref link Pubmed link , , , et al.
- 266 A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest 1997;100:1256–63. Cross Ref link Pubmed link , , , et al.
- 267 Synergy between a plasminogen cascade and MMP‐9 in autoimmune disease. J Clin Invest 2005;115:879–87. Cross Ref link Pubmed link , , , , , .
- 268 Dual targets for mouse mast cell protease‐4 in mediating tissue damage in experimental bullous pemphigoid. J Biol Chem 2011;286:37358–67. Cross Ref link Pubmed link , , , et al.
- 269 Gelatinase B‐deficient mice are resistant to experimental bullous pemphigoid. J Exp Med 1998;188:475–82. Cross Ref link Pubmed link , , , et al.
- 270 The serpin alpha1‐proteinase inhibitor is a critical substrate for gelatinase B/MMP‐9 in vivo. Cell 2000;102:647–55. Cross Ref link Pubmed link , , , et al.
- 271 A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest 2000;105:113–23. Cross Ref link Pubmed link , , , et al.
- 272 Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid. Matrix Biol 2012;31:38–44. Cross Ref link Pubmed link , , , et al.
- 273 Fc gamma receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid. Am J Pathol 2014;184:2185–96. Cross Ref link Pubmed link , , , et al.
- 274 Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild‐type mice. J Invest Dermatol 2007;127:2807–17. Cross Ref link Pubmed link , , , et al.
- 275 Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. J Autoimmun 2008;31:331–8. Cross Ref link Pubmed link , , , et al.
- 276 Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement‐dependent and ‐independent manner. J Immunol 2012;188:5792–9. Cross Ref link Pubmed link , , , et al.
- 277 A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen. J Immunol 2010;184:2166–74. Cross Ref link Pubmed link , , , et al.
- 278 Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice. J Immunol 2011;187:1176–83. Cross Ref link Pubmed link , , , et al.
- 279 Noncollagenous 16A domain of type XVII collagen‐reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model. Clin Immunol 2012;142:167–75. Cross Ref link Pubmed link , , , et al.
- 280 A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice. J Invest Dermatol 2007;127:2605–11. Cross Ref link Pubmed link , , , , , .
- 281 IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice. J Invest Dermatol 2007;127:1167–74. Cross Ref link Pubmed link , , , , .
- 282 Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. J Allergy Clin Immunol 2009;123:704–5. Cross Ref link Pubmed link , , , .
- 283 Omalizumab therapy for bullous pemphigoid. J Am Acad Dermatol 2014;71:468–74. Cross Ref link Pubmed link , , , , .
- 284 Rabbits immunized with a peptide encoded for by the 230‐kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid. J Invest Dermatol 1993;101:9–14. Cross Ref link Pubmed link , , , , .
- 285 Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230. J Autoimmun 2005;24:1–10. Cross Ref link Pubmed link , , , et al.
- 286 Trauma‐induced bullous pemphigoid. Clin Exp Dermatol 1989;14:245–9. Cross Ref link Pubmed link , .
- 287 Induced bullous pemphigoid. Br J Dermatol 1995;132:831–2. Cross Ref link Pubmed link , .
- 288 Burn‐induced bullous pemphigoid. J Am Acad Dermatol 1994;30:1027–8. Cross Ref link Pubmed link , , , .
- 289 Split skin grafting and bullous pemphigoid. Clin Exp Dermatol 1991;16:72–3. Cross Ref link Pubmed link , .
- 290 Bullous pemphigoid appearing both on thermal burn scars and split‐thickness skin graft donor sites. J Dtsch Dermatol Ges 2013;11:675–6. Pubmed link , , , , , .
- 291 Pemphigoid, bronchial neoplasm and radiotherapy. Proc R Soc Med 1967;60:1271–2. Pubmed link , , .
- 292 Radiation‐induced bullous pemphigoid: a systematic review of an unusual radiation side effect. Radiother Oncol 2007;82:5–9. Cross Ref link Pubmed link , , , et al.
- 293 Sun‐induced localized bullous pemphigoid. Br J Dermatol 1992;126:91–2. Cross Ref link Pubmed link , .
- 294 Bullous pemphigoid in a patient treated with UVA‐1 phototherapy for disseminated morphea. Dermatology 2001;202:54–7. Cross Ref link Pubmed link , , , , .
- 295 Bullous pemphigoid induced by PUVA therapy. Dermatology 1996;193:245–7. Cross Ref link Pubmed link , , , , , .
- 296 Localized bullous pemphigoid induced by photodynamic therapy. Photodermatol Photoimmunol Photomed 2011;27:251–3. Cross Ref link Pubmed link , , .
- 297 Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid. J Dermatol Case Rep 2011;5:74–6. Cross Ref link Pubmed link , .
- 298 Bullous pemphigoid triggered by influenza vaccination? Ecological study in Galicia, Spain. Br J Dermatol 2006;155:820–3. Cross Ref link Pubmed link , , , .
- 299 Furosemide‐induced bullous pemphigoid: case report and review of literature. J Drugs Dermatol 2006;5:562–4. Pubmed link , .
- 300 Risk factors for bullous pemphigoid in the elderly: a prospective case‐control study. J Invest Dermatol 2011;131:637–43. Cross Ref link Pubmed link , , , et al.
- 301 Modern diagnosis of autoimmune blistering skin diseases. Autoimmunity Rev 2010;10:84–9. Cross Ref link , .
- 302 U‐serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 2004;151:112–18. Cross Ref link Pubmed link , , , .
- 303 Direct immunofluorescence studies of sodium chloride‐separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 1990;22:664–70. Cross Ref link Pubmed link , , , , , .
- 304 Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. Arch Dermatol 1996;132:151–7. Cross Ref link Pubmed link , , , et al.
- 305 A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo‐bound IgG by laser scanning confocal microscopy. Arch Dermatol 2003;139:1007–11. Cross Ref link Pubmed link , , .
- 306 Human autoantibodies against the 230‐kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180‐kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest 1993;91:1608–15. Cross Ref link Pubmed link , , , , , .
- 307 [Immunopathologic changes in 115 patients with bullous pemphigoid.] Hautarzt 1999;50:866–72. Cross Ref link Pubmed link , , , , , .
- 308 Differentiating anti‐lamina lucida and anti‐sublamina densa anti‐BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride‐separated skin. J Invest Dermatol 1984;82:139–44. Cross Ref link Pubmed link , , , , .
- 309 Diagnostic value of indirect immunofluorescence on sodium chloride‐split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 1997;133:1102–7. Cross Ref link Pubmed link , , , .
- 310 Serological diagnosis of bullous pemphigoid (BP): comparison of the sensitivity of indirect immunofluorescence on salt‐split skin to immunoblotting. Br J Dermatol 1992;126:236–41. Cross Ref link Pubmed link , , , , , .
- 311 Bullous pemphigoid: serum antibody titre and antigen specificity. Exp Dermatol 1995;4:372–6. Cross Ref link Pubmed link , , , , , .
- 312 Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme‐linked immunosorbent assays for diagnosis of bullous pemphigoid. J Am Acad Dermatol 2013;69:748–53. Cross Ref link Pubmed link , , , , .
- 313 Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic‐based indirect immunofluorescence technique with the conventional multi‐step single test strategy. Orphanet J Rare Dis 2012;7:49. Cross Ref link Pubmed link , , , et al.
- 314 Geo‐epidemiology and autoimmunity. J Autoimmun 2010;34:J163–7. Cross Ref link Pubmed link , , , .
- 315 IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses. Br J Dermatol 2009;161:306–12. Cross Ref link Pubmed link , , , et al.
- 316 Diagnostic value of an enzyme‐linked immunosorbent assay using BP180 recombinant proteins in elderly patients with pruritic skin disorders. Br J Dermatol 2003;149:910–12. Cross Ref link Pubmed link , , , .
- 317 Anti‐bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. Arch Dermatol 2010;146:21–5. Pubmed link , , , , , .
- 318 A 230‐kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol 1989;92:33–8. Cross Ref link Pubmed link , , .
- 319 Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence. J Invest Dermatol 1989;92:171–4. Cross Ref link Pubmed link , , , , .
- 320 Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting. Br J Dermatol 2003;148:939–44. Cross Ref link Pubmed link , , , , .
- 321 LAD‐1, the linear IgA bullous dermatosis autoantigen, is a novel 120‐kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996;106:734–8. Cross Ref link Pubmed link , , , , .
- 322 Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus‐encoded form of bullous pemphigoid antigen 2. J Invest Dermatol 1998;110:282–6. Pubmed link , , , et al.
- 323 A highly sensitive and simple assay for the detection of circulating autoantibodies against full‐length bullous pemphigoid antigen 180. J Autoimmun 2002;18:299–309. Cross Ref link Pubmed link , , , et al.
- 324 Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins. J Invest Dermatol 1991;97:725–8. Cross Ref link Pubmed link , , , et al.
- 325 A common major histocompatibility complex class II allele HLA‐DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A 1996;93:8569–71. Cross Ref link Pubmed link , , , et al.
- 326 The association of HLA‐DQ7 with bullous pemphigoid is restricted to men. Br J Dermatol 1998;138:1085–90. Cross Ref link Pubmed link , , , , , .
- 327 HLA‐DR and DQ polymorphisms in bullous pemphigoid from northern China. Clin Exp Dermatol 2002;27:319–21. Cross Ref link Pubmed link , , , et al.
- 328 Polymorphisms of HLA‐DR and ‐DQ genes in Japanese patients with bullous pemphigoid. J Dermatol 2000;27:149–56. Cross Ref link Pubmed link , , , , .
- 329 Clinical features and practical diagnosis of bullous pemphigoid. Dermatol Clin 2011;29:427–38, viii–ix. Cross Ref link Pubmed link , , .
- 330 Bullous pemphigoid: physiopathology, clinical features and management. Adv Dermatol 2007;23:257–88. Cross Ref link Pubmed link , , .
- 331 Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort. Br J Dermatol 2012;167:1111–17. Cross Ref link Pubmed link , , , et al.
- 332 Clinical variants of pemphigoid. Int J Dermatol 1986;25:17–27. Cross Ref link Pubmed link , , .
- 333 Bullous pemphigoid. J Am Acad Dermatol 1987;16:907–24. Cross Ref link Pubmed link .
- 334 Two cases of dyshidrosiform pemphigoid with different presentations. Clin Exp Dermatol 2009;34:e151–3. Cross Ref link Pubmed link , , .
- 335 Pemphigoid nodularis (non‐bullous): a clinicopathological study of five cases. Br J Dermatol 2002;147:343–9. Cross Ref link Pubmed link , , , , , .
- 336 Pemphigoid nodularis: a report of three cases and review of the literature. Br J Dermatol 1997;136:398–401. Cross Ref link Pubmed link , .
- 337 Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoid. J Am Acad Dermatol 2002;47:133–6. Cross Ref link Pubmed link , , , et al.
- 338 Ecthyma‐gangrenosum‐like bullous pemphigoid. Dermatology 2010;221:142–8. Cross Ref link Pubmed link , , , , , .
- 339 Pemphigoid vegetans represents a bullous pemphigoid variant. Patient's IgG autoantibodies identify the major bullous pemphigoid antigen. J Am Acad Dermatol 1993;28:331–5. Cross Ref link Pubmed link , , , , , .
- 340 Pemphigoid vegetans. Br J Dermatol 1989;120:449–53. Cross Ref link Pubmed link , , , , , .
- 341 Pemphigoid vegetans. J Am Acad Dermatol 1994;30:649–50. Cross Ref link Pubmed link , , , .
- 342 Vesicular pemphigoid with circulating autoantibodies against 230‐kDa and 180‐kDa proteins, and additional autoantibodies against 97‐kDa and 45‐kDa proteins. Int J Dermatol 2007;46:206–9. Pubmed link , , , , .
- 343 Bullous pemphigoid presenting as exfoliative erythroderma. J Am Acad Dermatol 1998;39:827–30. Cross Ref link Pubmed link , , .
- 344 Unusual bullous disorder with features of toxic epidermal necrolysis, bullous pemphigoid and cicatricial pemphigoid. Clin Exp Dermatol 1995;20:65–9. Cross Ref link Pubmed link , , , , .
- 345 Localized pemphigoid (pretibial type) with IgG antibody to BP180 NC16a domain successfully treated with minocycline and topical corticosteroid. Clin Exp Dermatol 2007;32:759–61. Cross Ref link Pubmed link , , , et al.
- 346 Case of localized bullous pemphigoid with unique clinical manifestations in the lower legs. J Dermatol 2007;34:482–5. Cross Ref link Pubmed link , , , , , .
- 347 Localized bullous pemphigoid: a commonly delayed diagnosis. Int J Dermatol 2005;44:942–5. Cross Ref link Pubmed link , .
- 348 Localized flexural bullous pemphigoid. Indian J Dermatol 2008;53:157–8. Cross Ref link Pubmed link , .
- 349 Bullous pemphigoid with localized umbilical involvement. Acta Derm Venereol 2009;89:419–20. Cross Ref link Pubmed link , , .
- 350 Two cases of childhood bullous pemphigoid. Eur J Dermatol 2009;19:368–71. Pubmed link , , , , , .
- 351 Localized penile bullous pemphigoid of childhood. J Pediatr Urol 2008;4:395–7. Cross Ref link Pubmed link , , .
- 352 The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002;138:370–9. Pubmed link , , , et al.
- 353 Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts. J Am Acad Dermatol 2012;66:479–85. Cross Ref link Pubmed link , , , et al.
- 354 The events leading to the death of patients with pemphigus and pemphigoid. Br J Dermatol 1979;101:521–34. Cross Ref link Pubmed link .
- 355 A population‐based study of acute medical conditions associated with bullous pemphigoid. Br J Dermatol 2009;161:1149–52. Cross Ref link Pubmed link , , , .
- 356 Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study. Arch Dermatol 2009;145:537–42. Cross Ref link Pubmed link , , , et al.
- 357 Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study. JAMA Dermatol 2014;150:25–33. Cross Ref link Pubmed link , , , et al.
- 358 Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre. Br J Dermatol 2014;170:1319–26. Cross Ref link Pubmed link , , , , , .
- 359 A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002;346:321–7. Cross Ref link Pubmed link , , , et al.
- 360 Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases. Cutis 2005;76:205–9. Pubmed link , , , et al.
- 361 Prediction of survival for patients with bullous pemphigoid: a prospective study. Arch Dermatol 2005;141:691–8. Cross Ref link Pubmed link , , , et al.
- 362 High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 1998;134:465–9. Cross Ref link Pubmed link , , , , , .
- 363 Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol 1998;134:1075–80. Cross Ref link Pubmed link , , , et al.
- 364 S2k Guidelines for diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges 2015;13:713–27. Pubmed link , , , et al.
- 365 Histopathology of anti‐laminin 5 mucous membrane pemphigoid. J Am Acad Dermatol 2009;61:433–40. Cross Ref link Pubmed link , , , et al.
- 366 Histopathology of anti‐p200 pemphigoid. Am J Dermatopathol 2007;29:119–24. Cross Ref link Pubmed link , , , , , .
- 367 C3d immunohistochemistry on formalin‐fixed tissue is a valuable tool in the diagnosis of bullous pemphigoid of the skin. J Cutan Pathol 2010;37:654–8. Cross Ref link Pubmed link , , , , , .
- 368 Interventions for bullous pemphigoid. Cochrane Database Syst Rev 2010:CD002292. Pubmed link , , , , , .
- 369 A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol 2009;129:1681–7. Cross Ref link Pubmed link , , , et al.
- 370 A retrospective analysis of patients with bullous pemphigoid treated with methotrexate. Arch Dermatol 2008;144:612–16. Cross Ref link Pubmed link , , .
- 371 Chlorambucil as a steroid‐sparing agent in bullous pemphigoid. Br J Dermatol 2004;151:1107–8. Cross Ref link Pubmed link , , , .
- 372 Combined treatment with low‐dose methotrexate and initial short‐term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study. Br J Dermatol 2011;165:1337–43. Cross Ref link Pubmed link , , , et al.
- 373 Treatment of bullous pemphigoid with low‐dose oral cyclophosphamide: a case series of 20 patients. J Eur Acad Dermatol Venereol 2014;28:814–18. Cross Ref link Pubmed link , , .
- 374 Erythromycin therapy in bullous pemphigoid: possible anti‐inflammatory effects. J Am Acad Dermatol 1982;7:504–10. Cross Ref link Pubmed link , , .
- 375 [Cyclosporin in the treatment of bullous pemphigoid: preliminary study.] Ann Dermatol Venereol 1986;113:309–13. Pubmed link , , , et al.
- 376 Bullous pemphigoid treated with leflunomide: a novel immunomodulatory agent. Arch Dermatol 2000;136:1204–5. Cross Ref link Pubmed link , .
- 377 CD20‐directed therapy in autoimmune diseases involving the skin: role of rituximab. Exp Rev Dermatol 2008;3:259–78. Cross Ref link , .
- 378 Rituximab for treatment‐refractory pemphigus and pemphigoid: a case series of 17 patients. J Am Acad Dermatol 2011;65:552–8. Cross Ref link Pubmed link , , , , , .
- 379 Treatment of bullous pemphigoid with rituximab: critical analysis of the current literature. J Drugs Dermatol 2013;12:672–7. Pubmed link , .
- 380 Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption. Clin Exp Dermatol 2005;30:519–22. Cross Ref link Pubmed link , , , , .
- 381 Immunoadsorption for the treatment of bullous pemphigoid. Ther Apher 1997;1:372–6. Cross Ref link Pubmed link , , , , .
- 382 Immunoadsorption in dermatology. Arch Dermatol Res 2010;302:241–53. Cross Ref link Pubmed link , .
- 383 Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 2001;45:825–35. Cross Ref link Pubmed link .
- 384 Role of intravenous immunoglobulin in the treatment of bullous pemphigoid: analysis of current data. J Am Acad Dermatol 2001;44:83–8. Cross Ref link Pubmed link , .
- 385 High‐dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid. Eur J Dermatol 2012;22:363–9. Pubmed link , , , et al.
- 386 [Bullous pemphigoid. Guidelines for the diagnosis and treatment. Centres de reference des maladies bulleuses auto‐immunes. Societe Francaise de Dermatologie.] Ann Dermatol Venereol 2011;138:247–51. Cross Ref link Pubmed link , , , , .
- 387 British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol 2012;167:1200–14. Cross Ref link Pubmed link , , , , .
- 388 Pemphigoid. Guidelines for diagnosis and treatment. , , , et al.
- 389 S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges 2015;13:833–44. Pubmed link , , , et al.
- 390 Recommendations for the use of rituximab (anti‐CD20 antibody) in the treatment of autoimmune bullous skin diseases. J Dtsch Dermatol Ges 2008;6:366–73. Cross Ref link Pubmed link , , , et al.
- 391 Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases. J Dtsch Dermatol Ges 2007;5:881–7. Cross Ref link Pubmed link , , , et al.
- 392 Use of high‐dose immunoglobulins in dermatology. J Dtsch Dermatol Ges 2009;7:806–12. Pubmed link , , , et al.
- 393 Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol 2003;139:1051–9. Cross Ref link Pubmed link , .
- 394 Guidelines on the use of high‐dose intravenous immunoglobulin in dermatology. Eur J Dermatol 2009;19:90–8. Pubmed link .
- 395 A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol 2006;142:1447–54. Cross Ref link Pubmed link , , , et al.
- 396 Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol 1994;130:753–8. Cross Ref link Pubmed link , , , , , .
- 397 Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol 1993;129:49–53. Cross Ref link Pubmed link , , , et al.
- 398 [Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study.] Ann Dermatol Venereol 1993;120:518–21. Pubmed link , , , et al.
- 399 [Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study.] Ann Dermatol Venereol 1984;111:925–8. Pubmed link , .
- 400 Plasma exchange in bullous pemphigoid. Lancet 1984;2:486–8. Cross Ref link Pubmed link , , , et al.
- 401 Azathioprine plus prednisone in treatment of pemphigoid. BMJ 1978;2:1190–1. Cross Ref link Pubmed link , , , .
Mucous membrane pemphigoid
- 402 The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002;138:370–9. Pubmed link , , , et al.
- 403 Pemphigoid diseases. Lancet 2013;381:320–32. Cross Ref link Pubmed link , .
- 404 Cicatricial pemphigoid. J Am Acad Dermatol 1991;24:987–1001. Cross Ref link Pubmed link , , .
- 405 Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 2004;111:45–52. Cross Ref link Pubmed link , , .
- 406 Pemphigus. Medicine 1953;32:1–123. Cross Ref link Pubmed link .
- 407 Historical background. In: Wojnarowska F, Briggaman RA, eds. Management of Blistering Diseases. London: Chapman and Hall Medical, 1990:1–12. Cross Ref link .
- 408 Cicatricial pemphigoid. J Am Acad Dermatol 2000;43:571–91; quiz 591–74. Cross Ref link Pubmed link , .
- 409 Pemphigus of the skin and mucous membranes. Br J Dermatol 1889;1:175–81. , .
- 410 Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra‐ and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol 2001;145:778–83. Cross Ref link Pubmed link , , , et al.
- 411 Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br J Dermatol 1998;138:602–10. Cross Ref link Pubmed link , , , et al.
- 412 Anti‐epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 2001;357:1850–1. Cross Ref link Pubmed link , , , , , .
- 413 Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice. Clin Immunol 2000;95:26–32. Cross Ref link Pubmed link , , , .
- 414 Human anti‐laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model. J Invest Dermatol 2000;114:178–84. Cross Ref link Pubmed link , , , .
- 415 Passive transfer of anti‐laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 1996;98:1509–18. Cross Ref link Pubmed link , , , , .
- 416 The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1999;40:2283–90. Pubmed link , , , et al.
- 417 Identification of an epitope within human integrin alpha 6 subunit for the binding of autoantibody and its role in basement membrane separation in oral pemphigoid. J Immunol 2006;176:1968–77. Cross Ref link Pubmed link , , .
- 418 Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 1995;131:48–52. Cross Ref link Pubmed link , , , et al.
- 419 Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009;7:434–40. Pubmed link , , , .
- 420 Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995;131:957–8. Cross Ref link Pubmed link , , , et al.
- 421 Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom. Eye (London) 2012;26:1199–208. Cross Ref link , , , , .
- 422 Cicatricial pemphigoid. Int J Dermatol 1986;25:90–6. Cross Ref link Pubmed link , .
- 423 A prospective study of upper aerodigestive tract manifestations of mucous membrane pemphigoid. Medicine (Baltimore) 2006;85:239–52. Cross Ref link Pubmed link , , , et al.
- 424 Development of ocular disease in patients with mucous membrane pemphigoid involving the oral mucosa. Br J Ophthalmol 2006;90:964–7. Cross Ref link Pubmed link , , , , .
- 425 Bullous pemphigoid, cicatricial pemphigoid, and pemphigus vulgaris. A comparative clinical survey of 278 cases. Oral Surg Oral Med Oral Pathol 1982;54:656–62. Cross Ref link Pubmed link , , .
- 426 Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol 1988;19:792–805. Cross Ref link Pubmed link , , , .
- 427 A case of anti‐epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: review of Japanese cases and evaluation of risk for internal malignancy. J Dermatol 2004;31:10–15. Cross Ref link Pubmed link , , , et al.
- 428 Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases? Arch Dermatol 1999;135:1091–8. Cross Ref link Pubmed link , , , , , .
- 429 No association between cicatricial pemphigoid and malignant disease. Br J Dermatol 1991;125:193–4. Cross Ref link Pubmed link , .
- 430 Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit. Clin Exp Dermatol 2007;32:637–41. Cross Ref link Pubmed link , , , , , .
- 431 Relationship between cancer and oral pemphigoid patients with antibodies to alpha6‐integrin. J Oral Pathol Med 2007;36:1–5. Cross Ref link Pubmed link , , , .
- 432 Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Br J Dermatol 2006;154:90–8. Cross Ref link Pubmed link , , , et al.
- 433 Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 1992;90:1628–33. Cross Ref link Pubmed link , , , et al.
- 434 Prevalence and clinical significance of anti‐laminin 332 autoantibodies detected by a novel enzyme‐linked immunosorbent assay in mucous membrane pemphigoid. JAMA Dermatol 2013;149:533–40. Cross Ref link Pubmed link , , , et al.
- 435 Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid. J Dermatol Sci 1998;17:39–44. Cross Ref link Pubmed link , , , et al.
- 436 A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5. J Am Acad Dermatol 1998;38:624–7. Cross Ref link Pubmed link , , , et al.
- 437 Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5. J Am Acad Dermatol 2005;52:S90–2. Cross Ref link Pubmed link , , , , .
- 438 Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 1996;106:141–6. Cross Ref link Pubmed link , , , et al.
- 439 Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol 1997;108:901–7. Cross Ref link Pubmed link , , , et al.
- 440 Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain. J Dermatol Sci 2002;28:68–75. Cross Ref link Pubmed link , , , et al.
- 441 Cicatricial pemphigoid sera specifically react with the most C‐terminal portion of BP180. J Dermatol Sci 2003;32:59–64. Cross Ref link Pubmed link , , .
- 442 The 120‐kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis. Br J Dermatol 2000;143:104–11. Cross Ref link Pubmed link , , , , .
- 443 Anti‐basement membrane autoantibodies in patients with anti‐epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 1995;105:543–8. Cross Ref link Pubmed link , , , .
- 444 Antigen specificity in subsets of mucous membrane pemphigoid. J Invest Dermatol 2006;126:2631–6. Cross Ref link Pubmed link , , .
- 445 Autoantibodies to human alpha6 integrin in patients with oral pemphigoid. J Dent Res 2001;80:1711–15. Cross Ref link Pubmed link , , , , .
- 446 Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci U S A 1996;93:14714–19. Cross Ref link Pubmed link , , , , , .
- 447 The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4. J Immunol 2000;165:2824–9. Cross Ref link Pubmed link , , , , , .
- 448 Cicatricial pemphigoid. Immunofluorescent studies. Arch Dermatol 1972;106:195–9. Cross Ref link Pubmed link , , , , , .
- 449 Salt‐split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies. J Am Acad Dermatol 1991;24:952–8. Cross Ref link Pubmed link , , , , , .
- 450 The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol 1991;97:259–63. Cross Ref link Pubmed link , , , , , .
- 451 Cicatricial pemphigoid: serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity. Br J Dermatol 1999;140:645–50. Cross Ref link Pubmed link , , , , , .
- 452 Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin‐332 and type XVII collagen. Br J Dermatol 2012;166:1116–20. Cross Ref link Pubmed link , , , et al.
- 453 Circulating IgA and IgE autoantibodies in antilaminin‐332 mucous membrane pemphigoid. Br J Dermatol 2010;162:513–17. Cross Ref link Pubmed link , , , et al.
- 454 In vitro organ culture model for mucous membrane pemphigoid. Clin Immunol 2001;98:229–34. Cross Ref link Pubmed link , , , .
- 455 Identification of epitopes within integrin beta4 for binding of autoantibodies in ocular cicatricial and mucous membrane pemphigoid‐preliminary report. Invest Ophthalmol Vis Sci 2013;54:7707–16. Cross Ref link Pubmed link , , .
- 456 Influence of intravenous immunoglobulin therapy on serum levels of anti‐beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study. Curr Eye Res 2000;21:646–54. Cross Ref link Pubmed link , , , .
- 457 Rapid effector function of circulating NC16A‐specific T cells in individuals with mucous membrane pemphigoid. Br J Dermatol 2004;151:1160–4. Cross Ref link Pubmed link , , , et al.
- 458 Ocular cicatricial pemphigoid review. Curr Opin Allergy Clin Immunol 2004;4:435–9. Cross Ref link Pubmed link , .
- 459 Conjunctival interleukin‐13 expression in mucous membrane pemphigoid and functional effects of interleukin‐13 on conjunctival fibroblasts in vitro. Am J Pathol 2009;175:2406–15. Cross Ref link Pubmed link , , , et al.
- 460 Tumor necrosis factor‐alpha in ocular mucous membrane pemphigoid and its effect on conjunctival fibroblasts. Invest Ophthalmol Vis Sci 2009;50:5310–17. Cross Ref link Pubmed link , , , , , .
- 461 Histopathology of anti‐laminin 5 mucous membrane pemphigoid. J Am Acad Dermatol 2009;61:433–40. Cross Ref link Pubmed link , , , et al.
- 462 Cicatricial pemphigoid. Trans Am Ophthalmol Soc 1986;84:527–663. Pubmed link .
- 463 Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin‐332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients. Br J Dermatol 2011;165:815–22. Cross Ref link Pubmed link , , , , , .
- 464 Direct immunofluorescence studies of sodium chloride‐separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 1990;22:664–70. Cross Ref link Pubmed link , , , , , .
- 465 A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo‐bound IgG by laser scanning confocal microscopy. Arch Dermatol 2003;139:1007–11. Cross Ref link Pubmed link , , .
- 466 Diagnostic value of indirect immunofluorescence on sodium chloride‐split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 1997;133:1102–7. Cross Ref link Pubmed link , , , .
- 467 The use of chemically split tissue in the detection of circulating anti‐basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol 1988;118:31–40. Cross Ref link Pubmed link , .
- 468 Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol 1990;94:630–5. Cross Ref link Pubmed link , , , et al.
- 469 Anti‐epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy. J Am Acad Dermatol 2003;48:542–7. Cross Ref link Pubmed link , , , , .
- 470 Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectronmicroscopy. J Invest Dermatol 1991;97:3–9. Cross Ref link Pubmed link , , , , , .
- 471 A common major histocompatibility complex class II allele HLA‐DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A 1996;93:8569–71. Cross Ref link Pubmed link , , , et al.
- 472 Association of autoimmunity and cicatricial pemphigoid: is there an immunogenetic basis? J Am Acad Dermatol 1991;25:1011–15. Cross Ref link Pubmed link , , , .
- 473 Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci U S A 1994;91:7747–51. Cross Ref link Pubmed link , , , et al.
- 474 HLA‐DRB1 and HLA‐DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians. Eur J Dermatol 1998;8:330–3. Pubmed link , , , , , , .
- 475 Mucous membrane pemphigoid: HLA‐DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br J Dermatol 2001;145:406–14. Cross Ref link Pubmed link , , , et al.
- 476 HLA‐DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity. Br J Dermatol 2001;145:805–8. Cross Ref link Pubmed link , , , et al.
- 477 Significantly increased occurrence of HLA‐DQB1*0301 allele in patients with ocular cicatricial pemphigoid. J Invest Dermatol 1997;108:129–32. Cross Ref link Pubmed link , , .
- 478 Report on the sequence of DQB1*0301 gene in ocular cicatricial pemphigoid patients. Curr Eye Res 1992;11:1233–8. Cross Ref link Pubmed link , , , .
- 479 Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid. Proc Natl Acad Sci U S A 1991;88:11579–82. Cross Ref link Pubmed link , , , et al.
- 480 HLA antigens in ocular cicatricial pemphigoid. Br J Ophthalmol 1978;62:265–7. Cross Ref link Pubmed link , , .
- 481 Vulvar involvement in autoimmune bullous diseases. J Reprod Med 1993;38:101–7. Pubmed link , , , , .
- 482 Ocular mucous membrane pemphigoid: diagnosis and management strategies. Ocul Surf 2008;6:128–42. Cross Ref link Pubmed link , .
- 483 Acquired bullous diseases of childhood: re‐evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting. Br J Dermatol 1994;130:610–16. Cross Ref link Pubmed link , , , , , .
- 484 Childhood vulval pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol 1999;140:308–12. Cross Ref link Pubmed link , , , et al.
- 485 Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 1982;89:340–53. Cross Ref link Pubmed link , , .
- 486 Ocular cicatricial pemphigoid. Ophthalmology 1981;88:95–100. Cross Ref link Pubmed link , .
- 487 Autoimmune phenomena in ocular cicatricial pemphigoid. Am J Ophthalmol 1977;83:443–50. Cross Ref link Pubmed link , , , .
- 488 Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol 1983;96:453–9. Cross Ref link Pubmed link , .
- 489 Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea 1992;11:446–51. Cross Ref link Pubmed link , , .
- 490 Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. J Am Acad Dermatol 2015;72:168–74. Cross Ref link Pubmed link , , , et al.
- 491 Oral lesions of mucous membrane pemphigoid. A study of 85 cases. Arch Otolaryngol 1971;93:354–64. Cross Ref link Pubmed link , .
- 492 Oesophageal webs preceding carcinoma and rupture of the oesophagus in cicatricial pemphigoid. Clin Exp Dermatol 1991;16:395–8. Cross Ref link Pubmed link , , , , .
- 493 Benign mucous membrane pemphigoid. Arch Dermatol 1971;104:467–75. Cross Ref link Pubmed link , , , .
- 494 Bullous and cicatricial pemphigoid. Clinical, histopathologic, and immunopathologic correlations. Mayo Clin Proc 1977;52:54–66. Pubmed link , .
- 495 IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis. Br J Dermatol 2000;143:349–55. Cross Ref link Pubmed link , , , , , .
- 496 Comparative analysis of methods for detection of anti‐laminin 5 autoantibodies in patients with anti‐epiligrin cicatricial pemphigoid. J Am Acad Dermatol 2004;51:886–92. Cross Ref link Pubmed link , , , .
- 497 Usefulness of immunoblotting using purified laminin 5 in the diagnosis of anti‐laminin 5 cicatricial pemphigoid. J Dermatol Sci 2003;33:113–19. Cross Ref link Pubmed link , , , , , .
- 498 Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch Dermatol 2002;138:380–4. Cross Ref link Pubmed link , , , .
- 499 Pentoxifylline (anti‐tumor necrosis factor drug): effective adjuvant therapy in the control of ocular cicatricial pemphigoid. Eur J Ophthalmol 2011;21:529–37. Cross Ref link Pubmed link , , , , .
- 500 Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid. Br J Dermatol 2013;168:381–90. Cross Ref link Pubmed link , , , et al.
- 501 Intraoperative mitomycin C in the treatment of cicatricial obliterations of conjunctival fornices. Am J Ophthalmol 1996;122:728–30. Cross Ref link Pubmed link , .
- 502 Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Ophthalmology 1999;106:72–8, discussion 79. Cross Ref link Pubmed link , , , et al.
- 503 Methotrexate therapy for ocular cicatricial pemphigoid. Ophthalmology 2004;111:796–801. Cross Ref link Pubmed link , , , .
- 504 Treatment of mucous membrane pemphigoid with mycophenolate mofetil. Cornea 2013;32:810–15. Cross Ref link Pubmed link , , , , , .
- 505 Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. Ophthalmology 1999;106:2136–43. Cross Ref link Pubmed link , .
- 506 A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol 2004;111:303–10. Cross Ref link Pubmed link , , , , , .
- 507 Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy. Arch Dermatol 2001;137:1181–9. Cross Ref link Pubmed link , .
- 508 Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database Syst Rev 2009:CD004056. , , , .
- 509 Recalcitrant cicatricial pemphigoid treated with the anti‐TNF‐alpha agent etanercept. J Drugs Dermatol 2010;9:68–70. Pubmed link , , .
- 510 Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients. Arch Dermatol 2006;142:1457–61. Cross Ref link Pubmed link , , , , .
- 511 Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept. J Am Acad Dermatol 2002;46:113–15. Cross Ref link Pubmed link , , , , , .
- 512 Successful treatment of mucous membrane pemphigoid with infliximab. Arch Dermatol 2006;142:1268–70. Cross Ref link Pubmed link , .
- 513 Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes. Ophthalmology 2008;115:253–61, e251. Cross Ref link Pubmed link , , , et al.
- 514 Colchicine in the management of mucous membrane pemphigoid. Dermatol Ther 2011;24:443–5. Cross Ref link Pubmed link , , , .
- 515 Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol 2007;156:352–6. Cross Ref link Pubmed link , , , , .
- 516 Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature. J Am Acad Dermatol 2013;68:499–506. Cross Ref link Pubmed link , .
- 517 Rituximab for treatment‐refractory pemphigus and pemphigoid: a case series of 17 patients. J Am Acad Dermatol 2011;65:552–8. Cross Ref link Pubmed link , , , , , .
- 518 Rituximab for patients with refractory mucous membrane pemphigoid. Arch Dermatol 2011;147:843–9. Cross Ref link Pubmed link , , , et al.
- 519 CD20‐directed therapy in autoimmune diseases involving the skin: role of rituximab. Exp Rev Dermatol 2008;3:259–78. Cross Ref link , .
- 520 Treatment of mucous membrane pemphigoid with rituximab. J Am Acad Dermatol 2013;69:310–11. Cross Ref link Pubmed link , , .
- 521 Rituximab in severe pemphigus. Ann N Y Acad Sci 2009;1173:683–91. Cross Ref link Pubmed link , , .
- 522 [Mucous membrane pemphigoid. Guidelines for the diagnosis and treatment. Centres de reference des maladies bulleuses auto‐immunes. Societe Francaise de Dermatologie.] Ann Dermatol Venereol 2011;138:259–63. Cross Ref link Pubmed link , , , , .
- 523 Therapeutic approaches to patients with mucous membrane pemphigoid. Dermatol Clin 2011;29:637–41. Cross Ref link Pubmed link , .
- 524 Professional oral hygiene treatment and detailed oral hygiene instructions in patients affected by mucous membrane pemphigoid with specific gingival localization: a pilot study in 12 patients. Int J Dent Hyg 2012;10:138–41. Cross Ref link Pubmed link , , , et al.
- 525 Recommendations for the use of rituximab (anti‐CD20 antibody) in the treatment of autoimmune bullous skin diseases. J Dtsch Dermatol Ges 2008;6:366–73. Cross Ref link Pubmed link , , , et al.
- 526 Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases. J Dtsch Dermatol Ges 2007;5:881–7. Cross Ref link Pubmed link , , , et al.
- 527 [Treatment‐refractory anti‐laminin 332 mucous membrane pemphigoid. Remission following adjuvant immunoadsorption and rituximab.] Hautarzt 2011;62:852–8. Cross Ref link Pubmed link , , , , , .
- 528 Use of high‐dose immunoglobulins in dermatology. J Dtsch Dermatol Ges 2009;7:806–12. Pubmed link , , , et al.
- 529 Guidelines on the use of high‐dose intravenous immunoglobulin in dermatology. Eur J Dermatol 2009;19:90–8. Pubmed link .
Linear IgA bullous dermatosis
- 530 Pemphigoid diseases. Lancet 2013;381:320–32. Cross Ref link Pubmed link , .
- 531 Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol 1988;19:792–805. Cross Ref link Pubmed link , , , .
- 532 Linear IgA bullous dermatosis. Int J Dermatol 1999;38:818–27. Cross Ref link Pubmed link , .
- 533 Juvenile dermatitis herpetiformis versus “benign chronic bullous dermatosis of childhood.” Are these immunologic diseases? J Invest Dermatol 1975;65:447–50. Cross Ref link Pubmed link , , , , .
- 534 Diagnostic significance of the immunofluorescent pattern in dermatitis herpetiformis. Int J Dermatol 1975;14:429–36. Cross Ref link Pubmed link , .
- 535 Dermatitis herpetiformis and bullous pemphigoid. Intermediate and mixed forms. Arch Dermatol 1976;112:45–8. Cross Ref link Pubmed link , , , , .
- 536 Use of 1M NaCl split skin in the indirect immunofluorescence of the linear IgA bullous dermatoses. J Cutan Pathol 1990;17:144–8. Cross Ref link Pubmed link , , , , .
- 537 The localization of the target antigens and antibodies in linear IgA disease is heterogeneous, and dependent on the methods used. Br J Dermatol 1995;132:750–7. Cross Ref link Pubmed link , , , .
- 538 LAD‐1, the linear IgA bullous dermatosis autoantigen, is a novel 120‐kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996;106:734–8. Cross Ref link Pubmed link , , , , .
- 539 Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest 1990;85:812–20. Cross Ref link Pubmed link , , , .
- 540 Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults. Br J Dermatol 1991;124:157–62. Cross Ref link Pubmed link , , , , .
- 541 A case of linear IgA bullous dermatosis with IgA anti‐type VII collagen autoantibodies. Br J Dermatol 1996;134:336–9. Cross Ref link Pubmed link , , , et al.
- 542 Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin‐332 and type XVII collagen. Br J Dermatol 2012;166:1116–20. Cross Ref link Pubmed link , , , et al.
- 543 Circulating IgA and IgE autoantibodies in antilaminin‐332 mucous membrane pemphigoid. Br J Dermatol 2010;162:513–17. Cross Ref link Pubmed link , , , et al.
- 544 Linear IgA bullous dermatosis of childhood with autoantibodies to a 230 kDa epidermal antigen. Pediatr Dermatol 1994;11:139–44. Cross Ref link Pubmed link , , , , , .
- 545 Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol 1994;31:884–8. Cross Ref link Pubmed link , , , , , .
- 546 Linear immunoglobulin A (IgA) bullous dermatosis of childhood: identification of the target antigens and study of the cellular sources. Br J Dermatol 1996;135:785–90. Cross Ref link Pubmed link , , , .
- 547 Immunoblotting studies of linear IgA disease. J Dermatol Sci 1993;6:194–200. Cross Ref link Pubmed link , , , , , .
- 548 Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009;7:434–40. Pubmed link , , , .
- 549 Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol 2004;43:876–81. Cross Ref link Pubmed link , , , , .
- 550 Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2‐year review. Br J Dermatol 2002;147:476–80. Cross Ref link Pubmed link , .
- 551 Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995;131:957–8. Cross Ref link Pubmed link , , , et al.
- 552 Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients. Int J Dermatol 2006;45:1047–52. Cross Ref link Pubmed link , , , et al.
- 553 Juvenile blistering diseases: the problems of diagnosis and treatment. Asian Pac J Allergy Immunol 1986;4:133–7. Pubmed link , , .
- 554 Chronic bullous dermatosis of childhood–clinical and immunological features seen in African patients. Clin Exp Dermatol 1991;16:160–4. Cross Ref link Pubmed link , , , .
- 555 Bullous diseases in Malaysia: epidemiology and natural history. Int J Dermatol 1992;31:42–5. Cross Ref link Pubmed link .
- 556 Linear IgA bullous dermatosis in south India. Int J Dermatol 1997;36:191–3. Cross Ref link Pubmed link , , , .
- 557 [Iga linear bullous dermatosis in children. A series of 12 Tunisian patients.] Ann Dermatol Venereol 1994;121:888–92. Pubmed link , , , et al.
- 558 [Bullous IgA linear dermatosis of children in Mali.] Ann Dermatol Venereol 1996;123:544–8. Pubmed link , , .
- 559 Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors. Br J Dermatol 1990;123:447–52. Cross Ref link Pubmed link , , .
- 560 Linear IgA disease and ulcerative colitis. Br J Dermatol 1997;136:779–82. Cross Ref link Pubmed link , , , .
- 561 Linear IgA dermatosis: association with malignancy. J Am Acad Dermatol 1990;22:59–63. Cross Ref link Pubmed link , .
- 562 Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120‐kDa keratinocyte collagenous glycoprotein with antigenic cross‐reactivity to BP180. J Invest Dermatol 1997;108:423–9. Cross Ref link Pubmed link , , , , .
- 563 The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol 1998;110:207–10. Cross Ref link Pubmed link , , , .
- 564 The 97‐kDa (LABD97) and 120‐kDa (LAD‐1) fragments of bullous pemphigoid antigen 180/type XVII collagen have different N‐termini. J Invest Dermatol 2003;121:1554–6. Cross Ref link Pubmed link , , , et al.
- 565 Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9. J Biol Chem 2009;284:23386–96. Cross Ref link Pubmed link , , .
- 566 Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid. J Immunol 2010;185:4938–47. Cross Ref link Pubmed link , , , et al.
- 567 Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. J Invest Dermatol 1999;113:947–53. Cross Ref link Pubmed link , , , et al.
- 568 IgA autoantibodies against the NC16a domain of BP180 but not 120‐kDa LAD‐1 detected in a patient with linear IgA disease. Br J Dermatol 2008;158:1151–3. Cross Ref link Pubmed link , , , .
- 569 Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida‐type of linear IgA disease. Arch Dermatol Res 2001;293:109–14. Cross Ref link Pubmed link , , , et al.
- 570 Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule. Clin Immunol 2002;102:310–19. Cross Ref link Pubmed link , , , et al.
- 571 Chronic bullous disease of childhood and linear IgA disease of adults are IgA1‐mediated diseases. Br J Dermatol 1994;131:201–4. Cross Ref link Pubmed link , , .
- 572 Antigenic specificity of antibodies from patients with linear basement membrane deposition of IgA. Dermatology 1994;189 Suppl. 1:64–6. Cross Ref link Pubmed link , , et al.
- 573 Clinical correlations of linear IgA deposition at the cutaneous basement membrane zone. J Am Acad Dermatol 1989;20:761–70. Cross Ref link Pubmed link , .
- 574 Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun 2000;15:293–300. Cross Ref link Pubmed link , , , et al.
- 575 Mixed immunobullous disease: is this linear IgA disease? Australas J Dermatol 2000;41:219–21. Cross Ref link Pubmed link , , .
- 576 Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils. J Invest Dermatol 1990;94:667–72. Cross Ref link Pubmed link , , , .
- 577 Dermo‐epidermal blister formation by linear IgA dermatosis sera in normal human skin in organ culture. J Dermatol 1987;14:352–8. Cross Ref link Pubmed link , , , .
- 578 IgA autoimmune disorders: development of a passive transfer mouse model. J Investig Dermatol Symp Proc 2004;9:47–51. Cross Ref link Pubmed link , , , .
- 579 Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180‐ or 230‐kDa epidermal antigens. J Invest Dermatol 1997;108:854–8. Cross Ref link Pubmed link , , , .
- 580 Drug‐induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol 1997;136:406–11. Cross Ref link Pubmed link , , , et al.
- 581 The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. Br J Dermatol 2011;165:92–8. Cross Ref link Pubmed link , , , .
- 582 IgA anti‐p200 pemphigoid. Arch Dermatol 2012;147:1306–10. Cross Ref link , , , et al.
- 583 Localized linear IgA disease induced by ampicillin/sulbactam. J Am Acad Dermatol 2004;51:95–8. Cross Ref link Pubmed link , , , , .
- 584 Clinical, demographic, and immunohistologic features of vancomycin‐induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature. Medicine (Baltimore) 1999;78:1–8. Cross Ref link Pubmed link , , , .
- 585 A morbilliform variant of vancomycin‐induced linear IgA bullous dermatosis. Arch Dermatol 2008;144:774–8. Cross Ref link Pubmed link , , , .
- 586 Drug‐induced linear IgA bullous dermatosis. J Dermatol 2005;32:759–64. Cross Ref link Pubmed link , , , .
- 587 Drug‐induced linear immunoglobulin A disease. Clin Dermatol 1993;11:529–33. Cross Ref link Pubmed link , .
- 588 Linear IgA bullous dermatosis in one of two piroxicam‐induced eruptions: a distinct direct immunofluorescence trend revealed by the literature. J Am Acad Dermatol 2001;45:691–6. Cross Ref link Pubmed link , , .
- 589 Burn‐induced linear IgA dermatosis. J Eur Acad Dermatol Venereol 2000;14:507–10. Cross Ref link Pubmed link , , .
- 590 Linear IgA bullous dermatosis following influenza vaccination. Dermatol Online J 2009;15:3. , , , .
- 591 UV light‐induced linear IgA dermatosis. J Am Acad Dermatol 2004;50:109–15. Cross Ref link Pubmed link , , , , , .
- 592 Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid. Am J Dermatopathol 1983;5:547–54. Cross Ref link Pubmed link , , , .
- 593 The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis. Br J Dermatol 1999;140:1072–8. Cross Ref link Pubmed link , , , , , .
- 594 Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin‐332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients. Br J Dermatol 2011;165:815–22. Cross Ref link Pubmed link , , , , , .
- 595 U‐serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 2004;151:112–18. Cross Ref link Pubmed link , , , .
- 596 Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br J Dermatol 1999;141:867–75. Cross Ref link Pubmed link , , , , .
- 597 Mixed immunobullous disease of childhood: a good response to antimicrobials. Br J Dermatol 2001;144:769–74. Cross Ref link Pubmed link , , , , .
- 598 Linear IgA disease and pregnancy. J Am Acad Dermatol 1994;30:407–11. Cross Ref link Pubmed link , , .
- 599 A study of benign chronic bullous dermatosis of childhood and comparison with dermatitis herpetiformis and bullous pemphigoid occurring in childhood. Clin Exp Dermatol 1980;5:159–76. Cross Ref link Pubmed link , , , , .
- 600 Chronic bullous dermatosis of childhood persisting into adulthood. Pediatr Dermatol 1988;5:246–9. Cross Ref link Pubmed link , , .
- 601 Drug‐induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol 1994;30:187–92. Cross Ref link Pubmed link , , , , , .
- 602 Blister fluid for the diagnosis of subepidermal immunobullous diseases: a comparative study of basement membrane zone autoantibodies detected in blister fluid and serum. Br J Dermatol 1998;139:27–32. Cross Ref link Pubmed link , , , .
- 603 Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra‐ and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol 2001;145:778–83. Cross Ref link Pubmed link , , , et al.
- 604 The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol 2000;156:685–95. Cross Ref link Pubmed link , , , et al.
- 605 IgA antibodies of linear IgA bullous dermatosis recognize the 15th collagenous domain of BP180. J Invest Dermatol 2000;115:1164–6. Cross Ref link Pubmed link , , , et al.
- 606 Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases. Orphanet J Rare Dis 2011;6:31. Cross Ref link Pubmed link , , , et al.
- 607 Management of linear IgA disease. Dermatol Clin 2011;29:629–30. Cross Ref link Pubmed link , .
- 608 Innovative use of dapsone. Dermatol Clin 2010;28:599–610. Cross Ref link Pubmed link .
- 609 Linear IgA disease: successful application of immunoadsorption and review of the literature. Dermatology 2010;220:259–63. Cross Ref link Pubmed link , , , .
Anti‐p200 pemphigoid
- 610 Anti‐p200 pemphigoid. J Am Acad Dermatol 2014;71:185–91. Cross Ref link Pubmed link , , , .
- 611 A novel subepidermal blistering disease with autoantibodies to a 200‐kDa antigen of the basement membrane zone. J Invest Dermatol 1996;106:1333–8. Cross Ref link Pubmed link , , , et al.
- 612 Coexistence of psoriasis and an unusual IgG‐mediated subepidermal bullous dermatosis: identification of a novel 200‐kDa lower lamina lucida target antigen. Br J Dermatol 1996;134:340–6. Cross Ref link Pubmed link , , , , , .
- 613 Immunoglobulin G deposition to nonhemidesmosomal lamina lucida and early neutrophil involvement are characteristic features in a case of anti‐p200 pemphigoid. Br J Dermatol 2013;168:647–55. Cross Ref link Pubmed link , , , et al.
- 614 VII collagen. Br J Dermatol 2000;143:1043–9. Cross Ref link Pubmed link , , , et al
- 615 Anti‐p200 pemphigoid: diagnosis and treatment of a case presenting as an inflammatory subepidermal blistering disease. J Am Acad Dermatol 2002;46:786–9. Cross Ref link Pubmed link , , , .
- 616 Anti‐p200 pemphigoid: a novel autoimmune subepidermal blistering disease. J Dermatol 2007;34:1–8. Cross Ref link Pubmed link , , , , .
- 617 Anti‐laminin gamma‐1 pemphigoid. Proc Natl Acad Sci USA 2009;106:2800–5. Cross Ref link Pubmed link , , , et al.
- 618 The autoantigen in anti‐p200 pemphigoid is synthesized by keratinocytes and fibroblasts and is distinct from nidogen‐2. J Invest Dermatol 2008;128:87–95. Cross Ref link Pubmed link , , , , , .
- 619 Laminin isoforms containing the gamma3 chain are unable to bind to integrins due to the absence of the glutamic acid residue conserved in the C‐terminal regions of the gamma1 and gamma2 chains. J Biol Chem 2008;283:28149–57. Cross Ref link Pubmed link , , , et al.
- 620 Laminins. Cell Tissue Res 2010;339:259–68. Cross Ref link Pubmed link
- 621 Development of a simple enzyme‐linked immunosorbent assay for the detection of autoantibodies in anti‐p200 pemphigoid. Br J Dermatol 2011;164:76–82. Cross Ref link Pubmed link , , , et al.
- 622 From anti‐p200 pemphigoid to anti‐laminin gamma1 pemphigoid. J Dermatol 2010;37:231–8. Cross Ref link Pubmed link , , , et al.
- 623 Pathogenicity of autoantibodies in anti‐p200 pemphigoid. PLoS One 2012;7:e41769. Cross Ref link Pubmed link , , , et al.
- 624 IgA anti‐p200 pemphigoid. Arch Dermatol 2011;147:1306–10. Cross Ref link Pubmed link , , , , , , , .
- 625 A severe and refractory case of anti‐p200 pemphigoid resulting in multiple skin ulcers and scar formation. Dermatology 2009;218:265–71. Cross Ref link Pubmed link , , , et al.
- 626 Metastatic ovarian carcinoma‐associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features. Br J Dermatol 2008;158:1354–7. Cross Ref link Pubmed link , , , , , .
- 627 A case of epidermolysis bullosa acquisita with autoantibody to anti‐p200 pemphigoid antigen and exfoliative esophagitis. Dermatology 2006;212:381–4. Cross Ref link Pubmed link , , , et al.
- 628 Case of concurrent epidermolysis bullosa acquisita and anti‐p200 pemphigoid–how to treat it? Int J Dermatol 2007;46:295–8. Cross Ref link Pubmed link , , , , , , .
- 629 Relapse‐associated autoantibodies to BP180 in a patient with anti‐p200 pemphigoid. Clin Exp Dermatol 2010;35:614–17. Cross Ref link Pubmed link , , , .
- 630 Anti‐laminin gamma1 pemphigoid accompanied by autoantibodies to laminin alpha3 and gamma2 subunits of laminin‐332. JAMA Dermatol 2013;149:1437–9. Cross Ref link Pubmed link , , , et al.
- 631 A case of concurrent antilaminin gamma1 pemphigoid and antilaminin‐332‐type mucous membrane pemphigoid. Br J Dermatol 2014;171:1257–9. Cross Ref link Pubmed link , , , et al.
- 632 A case of anti‐p200 pemphigoid: evidence for a different pathway in neutrophil recruitment compared with bullous pemphigoid. Br J Dermatol 2009;160:462–4. Cross Ref link Pubmed link , , , .
- 633 An attempt to develop mouse model for anti‐laminin gamma1 pemphigoid. J Dermatol Sci 2013;70:108–15. Cross Ref link Pubmed link , , , et al.
- 634 Ex vivo pathogenicity of anti‐laminin gamma1 autoantibodies. Am J Pathol 2014;184:494–506. Cross Ref link Pubmed link , , , et al.
- 635 Form and function: the laminin family of heterotrimers. Dev Dyn 2000;218:213–34. Cross Ref link Pubmed link , .
- 636 Histopathology of anti‐p200 pemphigoid. Am J Dermatopathol 2007;29:119–24. Cross Ref link Pubmed link , , , , , .
- 637 Anti‐p200 pemphigoid in a 17‐year‐old girl successfully treated with systemic corticosteroid and dapsone. Br J Dermatol 2007;156:1075–8. Cross Ref link Pubmed link , , , et al.
- 638 Generalized annular bullous eruption–quiz case. Anti‐laminin gamma1 pemphigoid with a linear IgA bullous dermatosis‐like presentation. Arch Dermatol 2011;147:109–14. Cross Ref link Pubmed link , , , , , .
- 639 A successful treatment with ustekinumab in a case of antilaminin‐gamma1 pemphigoid associated with psoriasis. Br J Dermatol 2013;168:1367–9. Cross Ref link Pubmed link , , , et al.
- 640 Relapse‐associated autoantibodies to BP180 in a patient with anti‐p200 pemphigoid. Clin Exp Dermatol 2010;35:614–17. Cross Ref link Pubmed link , , , .
- 641 Refractory antilaminin gamma1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil. J Eur Acad Dermatol Venereol 2014;28:1401–3. Cross Ref link Pubmed link , , , et al.
- 642 Refractory anti‐laminin gamma1 pemphigoid with psoriasis vulgaris successfully treated by double‐filtration plasmapheresis. Eur J Dermatol 2013;23:715–16. Pubmed link , , , et al.
Epidermolysis bullosa acquisita
- 643 Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988;81:683–7. Cross Ref link Pubmed link , , , , , .
- 644 Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol 1971;103:1–10. Cross Ref link Pubmed link , , .
- 645 Epidermolysis bullosa acquisita – a pemphigoid‐like disease. J Am Acad Dermatol 1984;11:820–32. Cross Ref link Pubmed link , , , , .
- 646 Epidermolysis bullosa acquisita – a sign of cicatricial pemphigoid? Br J Dermatol 1979;101:475–84. Cross Ref link Pubmed link .
- 647 The spectrum of epidermolysis bullosa acquisita. Arch Dermatol 1979;115:1325–8. Cross Ref link Pubmed link , .
- 648 Two cases of epidermolysis bullosa. J Cutan Genitourin Dis 1895;13:10. .
- 649 The immunopathology of epidermolysis bullosa acquisita. Can Med Assoc J 1973;108:1143–6. Pubmed link .
- 650 Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol 1980;102:383–92. Cross Ref link Pubmed link , , , .
- 651 Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 1981;76:288–92. Cross Ref link Pubmed link , , , , .
- 652 Identification of the skin basement‐membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984;310:1007–13. Cross Ref link Pubmed link , , , , , .
- 653 Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol 2012;68:e89–95. Cross Ref link Pubmed link , , , et al.
- 654 Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. J Dermatol Sci 2011;62:169–75. Cross Ref link Pubmed link , , , et al.
- 655 U‐serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 2004;151:112–18. Cross Ref link Pubmed link , , , .
- 656 Pathogenesis of epidermolysis bullosa acquisita. Dermatol Clin 29:493–501, xi. Cross Ref link Pubmed link , .
- 657 Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 1995;131:48–52. Cross Ref link Pubmed link , , , et al.
- 658 Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009;7:434–40. Pubmed link , , , .
- 659 Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995;131:957–8. Cross Ref link Pubmed link , , , , , .
- 660 Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol 2004;43:876–81. Cross Ref link Pubmed link , , , , .
- 661 Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2‐year review. Br J Dermatol 2002;147:476–80. Cross Ref link Pubmed link , .
- 662 The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. Br J Dermatol 2011;165:92–8. Cross Ref link Pubmed link , , , .
- 663 Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases. Acta Derm Venereol 2011;91:307–12. Cross Ref link Pubmed link , , .
- 664 A common major histocompatibility complex class II allele HLA‐DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A 1996;93:8569–71. Cross Ref link Pubmed link , , , et al.
- 665 Epidermolysis bullosa acquisita in childhood. Arch Dermatol 1997;133:1122–6. Cross Ref link Pubmed link , , , et al.
- 666 A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple‐helical domain of type VII collagen. Lab Invest 1997;77:623–32. Pubmed link , , , et al.
- 667 [Epidermolysis bullosa acquisita of childhood.] Ann Dermatol Venereol 2009;136:513–17. Cross Ref link Pubmed link , , , et al.
- 668 Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature. J Am Acad Dermatol 1991;24:706–14. Cross Ref link Pubmed link , , , .
- 669 Bullous pemphigoid and epidermolysis bullosa acquisita: presentation, prognosis, and immunopathology in 11 children. Pediatr Dermatol 1998;15:184–90. Cross Ref link Pubmed link , , , et al.
- 670 Increased frequency of HLA‐DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 1988;91:228–32. Cross Ref link Pubmed link , , , , , .
- 671 Black patients of African descent and HLA‐DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita. J Invest Dermatol 2011;131:2386–93. Cross Ref link Pubmed link , , , et al.
- 672 The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn's disease have autoantibodies to type VII collagen. J Invest Dermatol 2002;118:1059–64. Cross Ref link Pubmed link , , , et al.
- 673 Autoimmunity against type VII collagen in inflammatory bowel disease. J Cell Mol Med 14:2393–403. Cross Ref link Pubmed link , , .
- 674 Subclass distribution of type VII collagen‐specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci 2005;37:182–4. Cross Ref link Pubmed link , , , , .
- 675 Autoantibody‐induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita. J Pathol 2011;224:234–44. Cross Ref link Pubmed link , , , et al.
- 676 Epidermolysis bullosa acquisita: what's new? J Dermatol 2010;37:220–30. Cross Ref link Pubmed link , , , et al.
- 677 Epidermolysis bullosa acquisita: Autoimmunity to anchoring fibril collagen. Autoimmunity 2012;45:91–101. Cross Ref link Pubmed link , , , .
- 678 Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. ISRN Dermatol 2013;2013:812029. Cross Ref link Pubmed link .
- 679 Malignancies in pemphigus and pemphigoid diseases. J Invest Dermatol 2015;135:1445–7. Cross Ref link Pubmed link , , , , , .
- 680 Autoantibodies to type VII collagen recognize epitopes in a fibronectin‐like region of the noncollagenous (NC1) domain. J Invest Dermatol 1993;100:618–22. Cross Ref link Pubmed link , , , et al.
- 681 Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993;92:1831–9. Cross Ref link Pubmed link , , , et al.
- 682 The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am J Pathol 2007;170:2009–18. Cross Ref link Pubmed link , , , et al.
- 683 Development of an ELISA for rapid detection of anti‐type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 1997;108:68–72. Cross Ref link Pubmed link , , , , , .
- 684 Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain‐specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol 2004;150:843–51. Cross Ref link Pubmed link , , , et al.
- 685 Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol 2002;147:592–7. Cross Ref link Pubmed link , , , et al.
- 686 Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3. Arch Dermatol 2000;136:227–31. Cross Ref link Pubmed link , , , et al.
- 687 A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading. J Am Acad Dermatol 2004;51:118–22. Cross Ref link Pubmed link , , , , .
- 688 A case of anti‐p200 pemphigoid with autoantibodies against both a novel 200‐kD dermal antigen and the 290‐kD epidermolysis bullosa acquisita antigen. Dermatology 2004;209:145–8. Cross Ref link Pubmed link , , , et al.
- 689 Congenital epidermolysis bullosa acquisita: vertical transfer of maternal autoantibody from mother to infant. Arch Dermatol 2010;147:337–41. Cross Ref link Pubmed link , , , , , .
- 690 Serum levels of anti‐type VII collagen antibodies detected by enzyme‐linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions. J Eur Acad Dermatol Venereol 2012;27:e224–30. Cross Ref link Pubmed link , , , et al.
- 691 Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol 1995;131:590–5. Cross Ref link Pubmed link , , , et al.
- 692 Induction of complement‐fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol 2006;177:3461–8. Cross Ref link Pubmed link , , , , , , .
- 693 Autoantibodies to type VII collagen mediate Fcgamma‐dependent neutrophil activation and induce dermal‐epidermal separation in cryosections of human skin. Am J Pathol 2002;161:301–11. Cross Ref link Pubmed link , , , , .
- 694 Induction of dermal–epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 2005;115:870–8. Cross Ref link Pubmed link , , , et al.
- 695 Evidence that anti‐type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005;124:958–64. Cross Ref link Pubmed link , , , , , .
- 696 Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 2006;126:1323–30. Cross Ref link Pubmed link , , , et al.
- 697 T cells are required for the production of blister‐inducing autoantibodies in experimental epidermolysis bullosa acquisita. J Immunol 2010;184:1596–603. Cross Ref link Pubmed link , , , et al.
- 698 Heat‐shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets. Blood 2011;117:6135–42. Cross Ref link Pubmed link , , , et al.
- 699 T and B cells target identical regions of the non‐collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita. Clin Immunol 2010;135:99–107. Cross Ref link Pubmed link , , , et al.
- 700 Genetic identification and functional validation of FcgammaRIV as key molecule in autoantibody‐induced tissue injury. J Pathol 2012;228:8–19. Pubmed link , , , et al.
- 701 Caspase‐1‐Independent IL‐1 Release mediates blister formation in autoantibody‐induced tissue injury through modulation of endothelial adhesion molecules. J Immunol 2015;194:3656–63. Cross Ref link Pubmed link , , , et al.
- 702 Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita. J Invest Dermatol 2015;135:916–19. Cross Ref link Pubmed link , , , et al.
- 703 Anti‐inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin‐1. Nat Med 2012;18:1401–6. Cross Ref link Pubmed link , , , et al.
- 704 Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen. J Autoimmun 2012;39:304–14. Cross Ref link Pubmed link , , , et al.
- 705 The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita. J Immunol 2007;178:6514–21. Cross Ref link Pubmed link , , , et al.
- 706 Recombinant IL‐6 treatment protects mice from organ specific autoimmune disease by IL‐6 classical signalling‐dependent IL‐1ra induction. J Autoimmun 2012;40:74–85. Cross Ref link Pubmed link , , , et al.
- 707 NADPH oxidase is required for neutrophil‐dependent autoantibody‐induced tissue damage. J Pathol 2007;212:56–65. Cross Ref link Pubmed link , , , , , .
- 708 Successful treatment of severe pemphigus with the combination of immunoadsorption and rituximab. J Invest Dermatol 2009;129:S97. , , , , , .
- 709 Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita. Eur J Immunol 2015;45:1462–70. Cross Ref link Pubmed link , , , et al.
- 710 Emerging treatments for pemphigoid diseases. Trends Mol Med 2013;19:501–12. Cross Ref link Pubmed link , , , , .
- 711 Drug‐induced epidermolysis bullosa acquisita with antibodies to type VII collagen. J Am Acad Dermatol 2002;46:S161–4. Cross Ref link Pubmed link , , , et al.
- 712 Epidermolysis bullosa acquisita with ultraviolet radiationsensitivity. Br J Dermatol 2000;142:517–20. Cross Ref link Pubmed link , , , .
- 713 Metal sensitization precipitates skin blistering in epidermolysis bullosa acquisita. J Dermatol 2010;37:280–2. Cross Ref link Pubmed link , , , et al.
- 714 Drug‐induced linear IgA disease with antibodies to collagen VII. Br J Dermatol 1998;138:310–14. Cross Ref link Pubmed link , , , .
- 715 The presence of intra‐lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. J Invest Dermatol 1989;92:27–32. Cross Ref link Pubmed link , , .
- 716 Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. Arch Dermatol 1996;132:151–7. Cross Ref link Pubmed link , , , et al.
- 717 A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo‐bound IgG by laser scanning confocal microscopy. Arch Dermatol 2003;139:1007–11. Cross Ref link Pubmed link , , .
- 718 Direct immunofluorescence studies of sodium chloride‐separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 1990;22:664–70. Cross Ref link Pubmed link , , , , , .
- 719 Linear IgA disease: a report of two dermal binding sera which recognize a pepsin‐sensitive epitope (?NC‐1 domain) of collagen type VII. Br J Dermatol 1997;137:526–33. Cross Ref link Pubmed link , , , , .
- 720 IgA‐mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol 2002;47:919–25. Cross Ref link Pubmed link , , , .
- 721 A case of linear IgA bullous dermatosis with IgA anti‐type VII collagen autoantibodies. Br J Dermatol 1996;134:336–9. Cross Ref link Pubmed link , , , et al.
- 722 Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol 1994;31:884–8. Cross Ref link Pubmed link , , , , , .
- 723 Distribution of HLA class II alleles in Korean patients with epidermolysis bullosa acquisita. Dermatology 1996;193:328–9. Cross Ref link Pubmed link , , .
- 724 Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita. J Invest Dermatol 2012;132:1409–15. Cross Ref link Pubmed link , , , et al.
- 725 Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. J Invest Dermatol 2011;131:167–76. Cross Ref link Pubmed link , , , et al.
- 726 Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. Arch Dermatol 1990;126:171–4. Cross Ref link Pubmed link , , .
- 727 Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). J Invest Dermatol 1985;85:79s–84s. Cross Ref link Pubmed link , , .
- 728 Epidermolysis bullosa acquisita and associated symptomatic esophageal webs. Arch Dermatol 1991;127:373–7. Cross Ref link Pubmed link , , .
- 729 Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid. Dermatology 1999;198:310–13. Cross Ref link Pubmed link , , , , , .
- 730 Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Autoimmunity 45:91–101. Cross Ref link Pubmed link , , , .
- 731 The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002;138:370–9. Pubmed link , , , et al.
- 732 Benign pemphigold; a report of seven cases with chronic, scarring, herpetiform plaques about the head and neck. AMA Arch Derm 1957;75:489–501. Cross Ref link Pubmed link , .
- 733 Acquired epidermolysis bullosa with the clinical feature of Brunsting‐Perry cicatricial bullous pemphigoid. Arch Dermatol 1991;127:391–5. Cross Ref link Pubmed link , , , , , .
- 734 A case of epidermolysis bullosa acquisita with clinical features of Brunsting–Perry pemphigoid showing an excellent response to colchicine. J Am Acad Dermatol 2009;61:715–19. Cross Ref link Pubmed link , , , et al.
- 735 Heterogeneity of Brunsting–Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290‐kD polypeptide along the lamina densa. J Dermatol 2011;38:887–92. Pubmed link , , , et al.
- 736 Pemphigoid diseases. Lancet 2013;381:320–32. Cross Ref link Pubmed link , .
- 737 Serum IgA autoantibodies in patients with epidermolysis bullosa acquisita: a high frequency of detection. Dermatology 2000;200:83–4. Cross Ref link Pubmed link .
- 738 An extract of cultured A431 cells contains major tissue antigens of autoimmune bullous diseases. Br J Dermatol 2000;143:821–3. Cross Ref link Pubmed link .
- 739 Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting. Br J Dermatol 2003;148:939–44. Cross Ref link Pubmed link , , , , .
- 740 The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. Eur J Dermatol 1998;8:83–5. Pubmed link , , , et al.
- 741 A routine immuno‐electron microscopic technique for localizing an auto‐antibody on epidermal basement membrane. Br J Dermatol 1984;110:1–7. Cross Ref link Pubmed link , , , , .
- 742 Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database Syst Rev 2009:CD004056. , , , .
- 743 Emerging treatment for epidermolysis bullosa acquisita. J Am Acad Dermatol 2001;44:818–28. Cross Ref link Pubmed link , .
- 744 Management of epidermolysis bullosa acquisita. Dermatol Clin 2011;29:643–7. Cross Ref link Pubmed link , .
- 745 [Epidermolysis bullosa acquisita. Guidelines for the diagnosis and treatment. Centres de reference des maladies bulleuses auto‐immunes. Societe Francaise de Dermatologie.] Ann Dermatol Venereol 2011;138:274–9. Cross Ref link Pubmed link , , , , .
- 746 Colchicine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1996;34:781–4. Cross Ref link Pubmed link , , .
- 747 Epidermolysis bullosa acquisita – successful treatment with colchicine. Arch Dermatol Res 1994;286:35–46. Cross Ref link Pubmed link , .
- 748 [Value of colchicine in treating acquired epidermolysis bullosa.] Ann Dermatol Venereol 1989;116:301–7. Pubmed link , .
- 749 Treatment of epidermolysis bullosa acquisita with the humanized anti‐Tac mAb daclizumab. Clin Immunol 2001;101:146–51. Cross Ref link Pubmed link , , , .
- 750 Epidermolysis bullosa acquisita treated with basiliximab, an interleukin‐2 receptor antibody. Acta Derm Venereol 2001;81:72. Cross Ref link Pubmed link , .
- 751 Immunoadsorption in dermatology. Arch Dermatol Res 2010;302:241–53. Cross Ref link Pubmed link , .
- 752 High‐dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases. Ann N Y Acad Sci 2010;38:186–95. , , , .
- 753 Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti‐CD20 antibody rituximab. Arch Dermatol 2006;142:147–50. Cross Ref link Pubmed link , , , , .
- 754 CD20‐directed therapy in autoimmune diseases involving the skin: role of rituximab. Exp Rev Dermatol 2008;3:259–78. Cross Ref link , .
- 755 Current concepts in the treatment of epidermolysis bullosa acquisita. Exp Opin Pharmacother 2011;12:1259–68. Cross Ref link , .
Bullous systemic lupus erythematosus
- 756 Bullous lichen planus: diagnosis by indirect immunofluorescence and treatment with dapsone. J Am Acad Dermatol 1986;14:464–9. Cross Ref link Pubmed link , , , .
- 757 Vesiculobullous systemic lupus erythematosus. A report of four cases. J Am Acad Dermatol 1988;18:93–100. Cross Ref link Pubmed link .
- 758 Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature. J Am Acad Dermatol 1983;9:924–33. Cross Ref link Pubmed link , .
- 759 Evidence that anti‐basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen. J Invest Dermatol 1985;84:472–6. Cross Ref link Pubmed link , , , .
- 760 Bullous systemic lupus erythematosus: revised criteria for diagnosis. Br J Dermatol 1995;132:921–8. Cross Ref link Pubmed link , , , , .
- 761 Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol 1993;100:28S–34S. Cross Ref link Pubmed link , .
- 762 Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy. Ann Intern Med 1982;97:165–70. Cross Ref link Pubmed link , , , .
- 763 Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988;81:683‐7. Cross Ref link Pubmed link , , , , , .
- 764 Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin‐5, laminin‐6, and type VII collagen. Arch Dermatol 1999;135:569–73. Cross Ref link Pubmed link , , , et al.
- 765 Bullous systemic lupus erythematosus with autoantibodies recognizing bullous pemphigoid antigen 1. Br J Dermatol 2005;153:232–3. Cross Ref link Pubmed link , , , , .
- 766 Bullous systemic lupus erythematosus. Dermatol Clin 2011;29:649–53. Cross Ref link Pubmed link , .
- 767 Bullous pemphigoid associated with systemic lupus erythematosus. Br J Dermatol 1998;139:927–8. Cross Ref link Pubmed link , , .
- 768 Linear IgA bullous dermatosis associated with systemic lupus erythematosus: a case report. Clin Rheumatol 2008;27:391–3. Cross Ref link Pubmed link , , , .
- 769 Direct immunofluorescence of bullous systemic lupus erythematosus. Arch Dermatol 1973;107:118–20. Cross Ref link Pubmed link , .
- 770 Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev 2010;10:84–9. Cross Ref link Pubmed link , .
- 771 The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. Br J Dermatol 2011;165:92–8. Cross Ref link Pubmed link , , , .
- 772 U‐serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 2004;151:112–18. Cross Ref link Pubmed link , , , .
- 773 Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 1995;131:48–52. Cross Ref link Pubmed link , , , et al.
- 774 Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009;7:434–40. Pubmed link , , , .
- 775 Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995;131:957–8. Cross Ref link Pubmed link , , , , , .
- 776 Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol 2004;43:876–81. Cross Ref link Pubmed link , , , , .
- 777 Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2‐year review. Br J Dermatol 2002;147:476–80. Cross Ref link Pubmed link , .
- 778 Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol 1996;135:355–62. Cross Ref link Pubmed link , , .
- 779 The spectrum of cutaneous manifestations in lupus erythematosus – the Italian experience. Lupus 2000;9:417–23. Cross Ref link Pubmed link , , , , .
- 780 Increased frequency of HLA‐DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 1988;91:228–32. Cross Ref link Pubmed link , , , , , .
- 781 Cutaneous manifestations of systemic lupus erythematosus in a tertiary referral center. Indian J Dermatol 2009;54:132–6. Cross Ref link Pubmed link , .
- 782 Bullous systemic lupus erythematosus. Clin Dermatol 2004;22:129–38. Cross Ref link Pubmed link .
- 783 Autoantibodies to type VII collagen recognize epitopes in a fibronectin‐like region of the noncollagenous (NC1) domain. J Invest Dermatol 1993;100:618–22. Cross Ref link Pubmed link , , , et al.
- 784 Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol 1995;131:590–5. Cross Ref link Pubmed link , , , et al.
- 785 Induction of complement‐fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol 2006;177:3461–8. Cross Ref link Pubmed link , , , et al.
- 786 Autoantibodies to type VII collagen mediate Fcgamma‐dependent neutrophil activation and induce dermal‐epidermal separation in cryosections of human skin. Am J Pathol 2002;161:301–11. Cross Ref link Pubmed link , , , , .
- 787 Induction of dermal–epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 2005;115:870–8. Cross Ref link Pubmed link , , , et al.
- 788 Evidence that anti‐type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005;124:958–64. Cross Ref link Pubmed link , , , , , .
- 789 Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 2006;126:1323–30. Cross Ref link Pubmed link , , , et al.
- 790 The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am J Pathol 2007;170:2009–18. Cross Ref link Pubmed link , , , et al.
- 791 The presence of anti‐basement membrane zone antibodies in the sera of patients with non‐bullous lupus erythematosus. Br J Dermatol 1997;136:222–6. Cross Ref link Pubmed link , , , , .
- 792 Penicillamine‐induced type II bullous systemic lupus erythematosus. Br J Dermatol 1997;136:474–5. Cross Ref link Pubmed link , , .
- 793 Bullous systemic lupus erythematosus. Int J Dermatol 1989;28:321–6. Cross Ref link Pubmed link , , , et al.
- 794 Methimazole‐induced bullous systemic lupus erythematosus: a case report. J Korean Med Sci 2012;27:818–21. Cross Ref link Pubmed link , , , .
- 795 Bullous systemic lupus erythematosus induced by UVB: report a case. J Med Assoc Thai 2012;95:969–73. Pubmed link , , .
- 796 Bullous eruption of systemic lupus erythematosus: a clinicopathological study of four cases. Br J Dermatol 1993;128:332–8. Cross Ref link Pubmed link , , , et al.
- 797 Bullous systemic lupus erythematosus with cutaneous mucinosis and leukocytoclastic vasculitis. J Am Acad Dermatol 1994;31:387–90. Cross Ref link Pubmed link , , , .
- 798 Bullous disease in systemic lupus erythematosus. J Am Acad Dermatol 1989;21:745–52. Cross Ref link Pubmed link , , , .
- 799 Facial bullous systemic lupus erythematosus. Int J Dermatol 1997;36:369–71. Pubmed link , , .
- 800 Dapsone in the management of autoimmune bullous diseases. Dermatol Clin 2011;29:561–4. Cross Ref link Pubmed link , .
- 801 Bullous systemic lupus erythematosus responding to mycophenolate mofetil. Eur J Dermatol 2010;20:844–5. Pubmed link , .
- 802 Are corticosteroids and immunosuppressors an efficacious treatment for bullous lupus erythematosus with systemic manifestations? Eur J Dermatol 2010;20:823–5. Pubmed link , , , , .
- 803 Rituximab in the treatment of bullous systemic lupus erythematosus. J Clin Rheumatol 2011;17:142–4. Cross Ref link Pubmed link , , , .
- 804 Bullous SLE: response to methotrexate and relationship with disease activity. Lupus 2003;12:63–6. Cross Ref link Pubmed link , , , , .
Very rare pemphigoid disorders
- 805 Lichen planus pemphigoides: four new cases and a review of the literature. Int J Dermatol 2013;52:406–12. Cross Ref link Pubmed link , , , et al.
- 806 Lichen planus pemphigoides: its relationship to bullous pemphigoid. Br J Dermatol 1991;125:263–71. Cross Ref link Pubmed link , , , et al.
- 807 Lichen planus pemphigoides: a clinicopathological study of nine cases. Histopathology 1991;19:147–54. Cross Ref link Pubmed link , , , , , .
- 808 Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C‐terminal NC16A domain of BP180. J Invest Dermatol 1999;113:117–21. Cross Ref link Pubmed link , , , et al.
- 809 Pemphigoid diseases. Lancet 2013;381:320–32. Cross Ref link Pubmed link , .
- 810 The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002;138:370–9. Pubmed link , , , et al.
- 811 Benign pemphigold; a report of seven cases with chronic, scarring, herpetiform plaques about the head and neck. AMA Arch Derm 1957;75:489–501. Cross Ref link Pubmed link , .
- 812 Brunsting–Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa? J Am Acad Dermatol 1993;28:89–92. Cross Ref link Pubmed link , , , et al.
- 813 Acquired epidermolysis bullosa with the clinical feature of Brunsting–Perry cicatricial bullous pemphigoid. Arch Dermatol 1991;127:391–5. Cross Ref link Pubmed link , , , , , .
- 814 A case of nonscarring subepidermal blistering disease associated with autoantibodies reactive with both type VII collagen and laminin 5. Dermatology 2003;207:61–4. Cross Ref link Pubmed link , , , et al.
- 815 Brunsting–Perry type pemphigoid with IgG autoantibodies to laminin‐332, BP230 and desmoplakins I/II. Br J Dermatol 2011;165:433–5. Cross Ref link Pubmed link , , , et al.
- 816 Brunsting–Perry pemphigoid of the scalp with antibodies against laminin 332. Dermatology 2011;222:193–5. Cross Ref link Pubmed link , , , .
- 817 Heterogeneity of Brunsting–Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290‐kD polypeptide along the lamina densa. J Dermatol 2011;38:887–92. Pubmed link , , , et al.
- 818 A case of epidermolysis bullosa acquisita with clinical features of Brunsting–Perry pemphigoid showing an excellent response to colchicine. J Am Acad Dermatol 2009;61:715–19. Cross Ref link Pubmed link , , , et al.
- 819 Brunsting–Perry cicatricial pemphigoid associated with autoantibodies to the C‐terminal domain of BP180. Br J Dermatol 2008;159:984–6. Cross Ref link Pubmed link , , , et al.
- 820 Localized pemphigoid (Brunsting–Perry type) with IgG antibody to BP180 NC16a domain resembling lupus erythematosus successfully treated with topical tacrolimus therapy. J Eur Acad Dermatol Venereol 2009;23:79–80. Cross Ref link Pubmed link , , , et al.
- 821 The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. Br J Dermatol 2011;165:92–8. Cross Ref link Pubmed link , , , .
- 822 Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases. Acta Derm Venereol 2011;91:307–12. Cross Ref link Pubmed link , , .
- 823 Brunsting–Perry‐type cicatricial pemphigoid with IgG autoantibodies to LAD‐1. Br J Dermatol 2014;170:743–5. Cross Ref link Pubmed link , , , .
- 824 Localized cicatricial pemphigoid (Brunsting–Perry): electron microscopic study. J Am Acad Dermatol 1989;21:1089–93. Cross Ref link Pubmed link , , .
- 825 Brunsting–Perry cicatricial pemphigoid precipitated by trauma. Arch Dermatol 1991;127:911–12. Cross Ref link Pubmed link , .
- 826 Brunsting–Perry type localized bullous pemphigoid, possibly induced by furosemide administration and sun exposure. Eur J Dermatol 2009;19:500–3. Pubmed link , , , , .
- 827 Brunsting–Perry pemphigoid simulating basal cell carcinoma. J Am Acad Dermatol 1989;21:331–4. Cross Ref link Pubmed link , , .
- 828 Brunsting perry cicatricial pemphigoid. Indian J Dermatol Venereol Leprol 2000;66:304–5. Pubmed link , , .
- 829 The alpha 5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency. J Biol Chem 2000;275:16002–6. Cross Ref link Pubmed link , , , .
- 830 Crescentic glomerulonephritis and subepidermal blisters with autoantibodies to alpha5 and alpha6 chains of type IV collagen. Lab Invest 2003;83:605–11. Cross Ref link Pubmed link , , , et al.
- 831 Identification and partial characterization of a novel 105‐kDalton lower lamina lucida autoantigen associated with a novel immune‐mediated subepidermal blistering disease. J Invest Dermatol 1993;101:262–7. Cross Ref link Pubmed link , , , et al.
- 832 A novel 105‐kDa lamina lucida autoantigen: association with bullous pemphigoid. J Invest Dermatol 1994;103:78–83. Cross Ref link Pubmed link , , , et al.
- 833 A novel immune‐mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component. Arch Dermatol 1994;130:343–7. Cross Ref link Pubmed link , .
- 834 A newly identified 105‐kD lower lamina lucida autoantigen is an acidic protein distinct from the 105‐kD gamma 2 chain of laminin‐5. J Invest Dermatol 1995;105:75–9. Cross Ref link Pubmed link , , , et al.
- 835 The 105‐kDa basement membrane autoantigen p105 is N‐terminally homologous to a tumor‐associated antigen. J Invest Dermatol 1996;107:209–14. Cross Ref link Pubmed link , .
- 836 Scarring autoimmune bullous disease in a Ugandan patient with autoantibodies to BP180, BP230, and laminin 5. J Am Acad Dermatol 2006;54:S43–6. Cross Ref link Pubmed link , , , , , .
- 837 The International Pemphigus and Pemphigoid Foundation. Dermatol Clin 2011;29:655–7. Cross Ref link Pubmed link , , , , , .
Other immunobullous diseases
Dermatitis herpetiformis
- 838 Landmark article, Aug 30, 1884: Dermatitis herpetiformis, by Louis A. Duhring. JAMA. 1983; 5 p. .
- 839 Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol 2011;64:1017–24, quiz 1025–6. Cross Ref link Pubmed link , .
- 840 Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis. J Am Acad Dermatol 2011;64:1027–33, quiz 1033–4. Cross Ref link Pubmed link , .
- 841 Advances in coeliac disease. Curr Opin Gastroenterol 2014;30:154–62. Cross Ref link Pubmed link , .
- 842 Celiac disease: a review. JAMA Pediatr 2014;168:272–8. Cross Ref link Pubmed link , .
- 843 Incidence and prevalence of dermatitis herpetiformis in a country in central Sweden, with comments on the course of the disease and IgA deposits as diagnostic criterion. Acta Derm Venereol 1984;64:144–50. Pubmed link .
- 844 Incidence and prevalence of dermatitis herpetiformis in western Sweden. Acta Derm Venereol 1984;64:400–4. Pubmed link , , .
- 845 Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population‐based study. Am J Gastroenterol 2014;109:757–68. Cross Ref link Pubmed link , , , , .
- 846 Reduced mortality in dermatitis herpetiformis: a population‐based study of 476 patients. Br J Dermatol 2012;167:1331–7. Cross Ref link Pubmed link , , , et al.
- 847 Dermatitis herpetiformis. Clin Dermatol 2012;30:56–9. Cross Ref link Pubmed link .
- 848 The incidence and prevalence of dermatitis herpetiformis in Utah. Arch Dermatol 1992;128:1608–10. Cross Ref link Pubmed link , , , .
- 849 Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics. J Am Dermatol 1990;22:436–9. Cross Ref link , , .
- 850 Dermatitis herpetiformis in Japan: an update. Dermatology 2002;204:37–42. Cross Ref link Pubmed link , , , et al.
- 851 Distinct characteristics in Japanese dermatitis herpetiformis: a review of all 91 Japanese patients over the last 35 years. Clin Dev Immunol 2012;2012:562168–9. Cross Ref link Pubmed link , , , et al.
- 852 Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. Am J Clin Dermatol 2003;4:13–20. Cross Ref link Pubmed link , .
- 853 Dermatitis herpetiformis: autoimmune disease associations. Clin Dermatol 1991;9:347–60. Cross Ref link Pubmed link , .
- 854 Lymphoma in patients with dermatitis herpetiformis and their first‐degree relatives. Br J Dermatol 2005;152:82–6. Cross Ref link Pubmed link , , , , .
- 855 Diseases associated with dermatitis herpetiformis. Br J Dermatol 1997;136:315–18. Cross Ref link Pubmed link , .
- 856 Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA‐B8/‐DR3. Am J Med 1990;88:145–50. Cross Ref link Pubmed link , , , , , .
- 857 The occurrence of type 1 diabetes in patients with dermatitis herpetiformis and their first‐degree relatives. Br J Dermatol 2004;150:136–8. Cross Ref link Pubmed link , , , , .
- 858 Dermatitis herpetiformis and celiac disease associated with Addison's disease. Arch Dermatol 1987;123:930–2. Cross Ref link Pubmed link , , .
- 859 Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797–801. Cross Ref link Pubmed link , , , et al.
- 860 Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002 Mar 18;195:747–57. Cross Ref link Pubmed link , , , , .
- 861 Transglutaminases in skin epidermis. Eur J Dermatol 2005;15:313–19. Pubmed link .
- 862 Recent advances in dermatitis herpetiformis. Clin Dev Immunol 2012;2012:914162–4. Cross Ref link Pubmed link .
- 863 Dermatitis herpetiformis: close to unravelling a disease. J Dermatol Sci 2004;34:83–90. Cross Ref link Pubmed link .
- 864 Absolute linkage of celiac disease and dermatitis herpetiformis to HLA‐DQ. Tissue Antigens 1997;50:52–6. Cross Ref link Pubmed link , , , , .
- 865 Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA‐DQ (alpha 1*0501, beta 1*02) or the HLA‐DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens 1997;49:29–34. Cross Ref link Pubmed link , , , , , .
- 866 A new model for dermatitis herpetiformis that uses HLA‐DQ8 transgenic NOD mice. J Clin Invest 2004;114:1090–7. Cross Ref link Pubmed link , , , et al.
- 867 HLA‐DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol 2002 Nov 15;169:5595–600. Cross Ref link Pubmed link , , .
- 868 First‐degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol 2002;37:51–5. Cross Ref link Pubmed link , , , , .
- 869 Incidence of familial dermatitis herpetiformis. Br J Dermatol 1996;134:394–8. Cross Ref link Pubmed link .
- 870 Concordance of dermatitis herpetiformis and celiac disease in monozygous twins. J Invest Dermatol 2000;115:990–3. Cross Ref link Pubmed link , , , , , .
- 871 Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut‐derived T cells in celiac disease. Nat Med 1998;4:713–17. Cross Ref link Pubmed link , , , et al.
- 872 The potassium iodide patch test in the dermatitis herpetiformis in relation to treatment with a gluten‐free diet and dapsone. Br J Dermatol 1980;103:313–17. Cross Ref link Pubmed link , , , , .
- 873 Adult coeliac disease, dermatitis herpetiformis and smoking. Gut 1997;40:289. Cross Ref link Pubmed link , , .
- 874 Dermatitis herpetiformis and cigarette smoking. Gut 1998;43:732. Cross Ref link Pubmed link , , .
- 875 Clinical and immunopathological features of 159 patients with dermatitis herpetiformis: an Italian experience. G Ital Dermatol Venereol 2013;148:163–9. Pubmed link , , , , .
- 876 Purpura in dermatitis herpetiformis. Br J Dermatol 1971;84:386–8. Pubmed link , .
- 877 Acral purpura as leading clinical manifestation of dermatitis herpetiformis: report of two adult cases with a review of the literature. Dermatology 2013;227:1–4. Cross Ref link Pubmed link , , , et al.
- 878 Oral mucosa is frequently affected in patients with dermatitis herpetiformis. Arch Dermatol 1998;134:756–8. Cross Ref link Pubmed link , , , , , .
- 879 Coeliac‐type dental enamel defects in patients with dermatitis herpetiformis. Acta Derm Venereol 1992;72:25–7. Pubmed link , , .
- 880 Dental enamel defects in children with dermatitis herpetiformis. J Pediatr 1991;118(4 Pt 1):572–4. Cross Ref link Pubmed link , , .
- 881 Coeliac‐type permanent‐tooth enamel defects. Ann Med 1996;28:9–12. Cross Ref link Pubmed link .
- 882 Celiac disease and other precursors to small‐bowel malignancy. Gastroenterol Clin North Am 2002;31:625–39. Cross Ref link Pubmed link , .
- 883 Neurologic presentation of celiac disease. Gastroenterology 2005;128(4 Suppl. 1):S92–7. Cross Ref link Pubmed link .
- 884 The neurologic significance of celiac disease biomarkers. Neurology 2014 Nov 11;83:1789–96. Cross Ref link Pubmed link , , , , .
- 885 A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. BMC Gastroenterol 2014;14:139. Cross Ref link Pubmed link , , , et al.
- 886 Remission in dermatitis herpetiformis: a cohort study. Arch Dermatol 2011;147:301–5. Cross Ref link Pubmed link , , .
- 887 Immunopathology of dermatitis herpetiformis. Clin Dermatol 1991;9:295–311. Cross Ref link Pubmed link , , , .
- 888 Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol 1996;132:912–18. Cross Ref link Pubmed link , , .
- 889 Management of dermatitis herpetiformis. Immunol Allergy Clin North Am 2012;32:275–81, vi–vii. Cross Ref link Pubmed link , .
- 890 Italian Group for Cutaneous Immunopathology. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol 2009;23:633–8. Cross Ref link Pubmed link , , , ,
- 891 25 years' experience of a gluten‐free diet in the treatment of dermatitis herpetiformis. Br J Dermatol 1994;131:541–5. Cross Ref link Pubmed link , , , , .
- 892 Protective effect of gluten‐free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996;135:363–7. Cross Ref link Pubmed link , , , et al.
- 893 Dapsone suppresses integrin‐mediated neutrophil adherence function. J Invest Dermatol 1992;98:135–40. Cross Ref link Pubmed link , , , , .
- 894 Dapsone and sulfones in dermatology: overview and update. J Am Dermatol 2001;45:420–34. Cross Ref link , .
- 895 Dapsone‐induced hemolytic anemia. Drug Metab Rev 1995;27(1–2):107–24. Cross Ref link Pubmed link , , .
- 896 Dapsone‐induced methemoglobinemia: a primer for clinicians. Ann Pharmacother 2011;45:1103–15. Cross Ref link Pubmed link , , .
- 897 Dapsone‐mediated agranulocytosis: risks, possible mechanisms and prevention. Toxicology 2001 Apr 12;162:53–60. Cross Ref link Pubmed link .
- 898 Hypersensitivity reactions to dapsone: a systematic review. Acta Derm Venereol 2012;92:194–9. Cross Ref link Pubmed link , , .
- 899 Dapsone‐induced peripheral neuropathy. Case report and review. Arch Dermatol 1984;120:356–9. Cross Ref link Pubmed link , , , .
- 900 G6PD deficiency: a classic example of pharmacogenetics with on‐going clinical implications. Br J Haematol 2014;164:469–80. Cross Ref link Pubmed link , .
- 901 The use of cimetidine to reduce dapsone‐dependent methaemoglobinaemia in dermatitis herpetiformis patients. Br J Clin Pharmacol 1992;34:244–9. Cross Ref link Pubmed link , , , et al.
- 902 Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. Br J Dermatol 1995;132:257–62. Cross Ref link Pubmed link , , , , , .
- 903 The use of cimetidine to reduce dapsone‐dependent haematological side‐effects in a patient with mucous membrane pemphigoid. Clin Exp Dermatol 2009;34:e1025–6. Cross Ref link Pubmed link , .
- 904 Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid. Br J Dermatol 1989;121:759–62. Cross Ref link Pubmed link , , , , .
- 905 Management of dermatitis herpetiformis. Dermatol Clin 2011;29:631–5. Cross Ref link Pubmed link , .
- 906 Sulfasalazine and dermatitis herpetiformis. Australas J Dermatol 2005;46:101–3. Cross Ref link Pubmed link , , , .
- 907 [Guideline “Coeliac disease and dermatitis herpetiformis”.] Ned Tijdschr Geneeskd 2010;154:A1904. Pubmed link , , , , , .
- 908 Centres de référence des maladies bulleuses auto‐immunes. Société Française de Dermatologie. [Dermatitis herpetiformis. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto‐immunes. Société Française de Dermatologie.] Ann Dermatol Vénéréol 2011; pp. 271–3. , , , , ,
- 909 [Clinical guidelines for the diagnosis and treatment of dermatitis herpetiformis.] Actas Dermosifiliogr 2010;101:820–6. Cross Ref link Pubmed link